世界*实验材料供应商 NIBSC上海金畔生物为其中国代理， NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

NIBSC中国代理, NIBSC上海代理， NIBSC北京代理，NIBSC广东代理， NIBSC江苏代理NIBSC湖北代理,NIBSC天津,NIBSC黑龙江代理,NIBSC内蒙古代理,NIBSC吉林代理,NIBSC福建代理, NIBSC江苏代理, NIBSC浙江代理, NIBSC四川代理,

NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

世界*实验材料供应商  NIBSC上海金畔生物为其中国代理，  NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

  NIBSC中国代理,  NIBSC上海代理，  NIBSC北京代理， NIBSC广东代理，  NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理,  NIBSC江苏代理,  NIBSC浙江代理,  NIBSC四川代理,

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心
NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

世界*实验材料供应商  NIBSC上海金畔生物为其中国代理，  NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

  NIBSC中国代理,  NIBSC上海代理，  NIBSC北京代理， NIBSC广东代理，  NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理,  NIBSC江苏代理,  NIBSC浙江代理,  NIBSC四川代理,

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心
NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

世界*实验材料供应商  NIBSC上海金畔生物为其中国代理，  NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

  NIBSC中国代理,  NIBSC上海代理，  NIBSC北京代理， NIBSC广东代理，  NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理,  NIBSC江苏代理,  NIBSC浙江代理,  NIBSC四川代理,

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心
NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

NIBSC供应的主要产品：

NIBSC提供生物医学研究领域大量的标准、参照品及试剂，包括WHO标准、流感试剂、质控试剂及其他欧盟认证的体外诊断试剂。在NIBSC的在线目录中，可以采购到所有生物制品参照材料、流感试剂及体外诊断产品。此外，NIBSC还供应AIDS试剂中心提供的超过6000种研究试剂，资源中心供应的Creutzfeldt-Jakob病评估、诊断及研究试剂。在细胞生物学研究领域，NIBSC还提供包括人类胚胎干细胞及其他干细胞等多种细胞株，用于科学研究及疾病疫苗测试。该系列主要产品包括：
一、标准生物制剂：该系列产品包括大量细胞因子/生长因子（如神经营养因子、各型白介素与干扰素、GDNF、VEGF）、内毒素、免疫球蛋白与免疫血清、蛋白激素及内分泌因子、大量诊断试剂及疫苗、干细胞株等。

二、AIDS中心供应的产品
NIBSC的CFAR是由医学研究协会资助下创建于1989年的HIV/AIDS试剂中心，是世界上仅有的的两个之一（欧洲*）致力于提供全部HIV/AIDS研究用试剂的研究中心。该中心目前供应的产品超过6000种，主要包括：各种HIV/AIDS研究用细胞株、病毒家系、DNA克隆、单/多克隆抗体、多肽、重组蛋白、细胞因子、趋化因子、抗HIV药物/复合物。

三、流感资源中心供应的产品
过去30年里，NIBSC 的流感资源中心在流感疫苗的生产与标准化中起着重要作用，流感疫苗研发与生产的关键问题在于流感病毒有着*的突变率，用于疫苗研发与生产的病毒株每隔一段时间须得更新，在WHO推荐用于疫苗生产和研发的流感病毒株选择上起着关键性作用。目前该中心为客户提供大量候选的流感疫苗、病毒、SRD试剂及唾液酸苷酶试剂。包括H1N1、H3N2、B (Yamagata lineage)、 B (Victoria lineage)。     

四、CJD研究与资源中心供应的产品
NIBSC的CJD研究与资源中心成立于2001，致力于研究与生产CJD鉴定试剂、探索在使用重组的prion蛋白作为培养基质的血样中TSE感染的标志物检测中如何放大检测结果的方法。同时为研究人员供应一系列CJD鉴定及研究用相关试剂及实验方法。     

五、英国干细胞库供应的产品
英国干细胞库 (UKSCB) 供应多种人/鼠/多能干细胞株及相关干细胞研究产品与研究方法与资料。     

六、病毒研究用质控血清
NIBSC供应大量病毒研究用质控血清，目录随时更新，详见公司。

部分产品报价如下：

NIBSC中国代理 英国国家生物标准与检定所

详细介绍

产品咨询

英国国家生物标准与检定所（National Institute for Biological Standards and Control, NIBSC），同时它又是世界卫生组织WHO的一个标准品供应中心，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。

产品价格表

00/410 MAPREC assay of poliovirus type 1 （Sabin）.100% 480-A, 525-C DNA（1st International Reference Preparation） 株 NIBSC 1900
00/416 MAPREC assay of poliovirus type 1 （Sabin） Low Mutant Virus Reference（1st International Reference Preparation） 株 NIBSC 1900
00/418 MAPREC assay of poliovirus type 1 （Sabin） （1st International Standard） 株 NIBSC 1900
00/422 MAPREC assay of poliovirus type 1 （Sabin） High Mutant Virus Reference（1st International Reference Preparation） 株 NIBSC 1900
00/440 Influenza anti A/Singapore/1/57 Serum （sheep） H2 株 NIBSC 1900
00/442 Influenza anti B/Yamanashi/166/98 Serum （sheep） 株 NIBSC 1900
00/464 Streptokinase 株 NIBSC 1900
00/500 Botulinum Antitoxin Human 株 NIBSC 1900
00/530 Influenza Virus infectious B/Sichuan/379/99 株 NIBSC 1900
00/532 Influenza Virus infectious B/Johannesburg/5/99 株 NIBSC 1900
00/542 Influenza anti A/Chick/Scotland/59 （H5N1） Serum （sheep） 株 NIBSC 1900
00/544 Influenza Virus infectious B/Victoria/504/00 株 NIBSC 1900
00/546 Influenza Antigen B/Johannesburg/5/99 株 NIBSC 1900
00/552 Influenza Antigen A/duck/Singapore/97 （H5N3） 株 NIBSC 1900
00/556 Influenza anti B/Johannesburg/5/99/ Serum （sheep） 株 NIBSC 1900
00/560 Hepatitis A Virus RNA NAT Assays 株 NIBSC 1900
00/572 Interferon Beta （Human, rDNA; CHO cell-derived; Glycosylated） 株 NIBSC 1900
00/574 Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated 株 NIBSC 1900
00/576 Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated 株 NIBSC 1900
00/588 Hepatitis B Surface Antigen （HBsAg） subtype adw2, genotype A 株 NIBSC 1900
00/614 Influenza Virus infectious B/Guangdong/120/00 株 NIBSC 1900
007SP Human Anti-Pneumococcal capsule Reference Serum （1st International Standard） 株 NIBSC 1900
007SP Human Anti-Pneumococcal capsule Reference Serum （1st International Standard） 株 NIBSC 1900
01/412 Anti-Meningococcal immunotype L3,7,9 mAb 株 NIBSC 1900
01/420 Interleukin-17 Human rec DNA 株 NIBSC 1900
01/424 Vascular Endothelial Growth Factor, Human rDNA derived 株 NIBSC 1900
01/426 Meningococcal group Y polysaccharide 株 NIBSC 1900
01/428 Meningococcal group W135 polysaccharide 株 NIBSC 1900
01/450 Influenza anti B/Guangdong/120/2000 Serum （sheep） 株 NIBSC 1900
01/452 Influenza anti A/Panama/2007/99 Serum （sheep） 株 NIBSC 1900
01/488 Hepatitis A Virus RNA Working Reagent for NAT assays 株 NIBSC 1900
01/506 Botulinum Antitoxin Equine Type F 株 NIBSC 1900
01/508 Botulinum Antitoxin Equine Type C 株 NIBSC 1900
01/510 Botulinum Antitoxin Equine Type D 株 NIBSC 1900
01/512 Botulinum Antitoxin Equine Type G 株 NIBSC 1900
01/514 Anti-Meningococcal Serosubtype P1.7 mAb 株 NIBSC 1900
01/528 Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] （Panel of 5 ampoules） 株 NIBSC 1900
01/530 Oral Poliovaccine Sabin Reference Preparation Type 2 （Panel of 5 ampoules） 株 NIBSC 1900
01/532 Oral Poliovaccine Sabin Reference Preparation Type 3 （Panel of 5 ampoules） 株 NIBSC 1900
01/538 Anti-Meningococcal Serosubtype P1.16 mAb 株 NIBSC 1900
01/546 Influenza Antigen B/Guangdong/120/2000 株 NIBSC 1900
01/572 Anti-D Immunoglobulin 株 NIBSC 1900
01/580 Thrombin, human, 2nd International Standard 株 NIBSC 1900
01/600 Anti-Toxoplasma IgG, Human 株 NIBSC 1900
01/608 Low Molecular Weight Heparin, 2nd International Standard 株 NIBSC 1900
01/612 Influenza Virus infectious B/Hawaii/10/01 株 NIBSC 1900
01/614 Influenza Antigen A/New Caledonia/20/99 株 NIBSC 1900
02/102 Influenza anti A/Panama/2007/99 Serum （sheep） 株 NIBSC 1900
02/144 Anti-Meningococcal Serosubtype P1.15 mAb 株 NIBSC 1900
02/148 Anti-Meningococcal Serosubtype P1.4 mAb 株 NIBSC 1900
02/168 Prekallikrein Activator （PKA）, Human 株 NIBSC 1900
02/176 Diphtheria Toxoid for use in Flocculation Test. 株 NIBSC 1900
02/178 Anti-Meningococcal Serosubtype P1.2 mAb 株 NIBSC 1900
02/180 Anti-Meningococcal Serotype P2.2a mAb 株 NIBSC 1900
02/182 Anti-Japanese Encephalitis Virus Plasma, Human 株 NIBSC 1900
02/184 Anti-Japanese Encephalitis （Anti-JE） Virus Control Plasma, Human 株 NIBSC 1900
02/186 Anti-Dengue Virus Types 1+2+3+4, Human 株 NIBSC 1900
02/206 Blood Coagulation Factor XIII, Plasma, Human 1st IS 株 NIBSC 1900
02/208 Haemophilus influenzae b PRP 株 NIBSC 1900
02/210 HIV （antibody）, 1st International Reference Panel 株 NIBSC 1900
02/226 IVIG negative control for use with IVIG + anti-D 株 NIBSC 1900
02/228 IVIG + anti-D for use with negative control IVIG 株 NIBSC 1900
02/254 Insulin-like growth Factor I 株 NIBSC 1900
02/262 Influenza Virus infectious B/Brisbane/32/2002 株 NIBSC 1900
02/264-003 HCV RNA Working Reagent for Nucleic Acid Amplification Techniques 株 NIBSC 1900
02/286 Vascular Endothelial Growth Factor 株 NIBSC 1900
02/294 Influenza anti A/chick/Italy/13474/99 （H7N1） Serum （sheep） 株 NIBSC 1900
02/306 Polio Virus Sabin Types 1, 2 and 3 株 NIBSC 1900
02/308 Anti-Meningococcal Serotype P3.4 mAb 株 NIBSC 1900
02/310 Anti-Meningococcal Serotype P3.15 mAb 株 NIBSC 1900
02/318 Botulinum Antitoxin Equine Type E 株 NIBSC 1900
02/320 Anti-Meningococcal Serosubtype P1.3 mAb 株 NIBSC 1900
02/336 Influenza Antigen A/New Caledonia/20/99 株 NIBSC 1900
02/338 Influenza anti A/Panama/2007/99 Serum （sheep） 株 NIBSC 1900
02/342 Protein C Plasma 株 NIBSC 1900
03/104-011 HTLV-1 （antibody） Monitor Sample 株 NIBSC 1900
03/110 Influenza anti B/Shangdong/9/97 Serum （sheep） 株 NIBSC 1900
03/114 Anti-Meningococcal Serosutype P1.1 mAb 株 NIBSC 1900
03/116 Blood Coagulation Factor V, Plasma（1st I.S.） 株 NIBSC 1900
03/124 Thrombopoietin, human rDNA derived 株 NIBSC 1900
03/142 Anti-Meningococcal Serosubtype P1.14 mAb 株 NIBSC 1900
03/148 Keratinocyte growth factor （KGF, FGF-7）（24-163） 株 NIBSC 1900
03/150 Keratinocyte Growth Factor （KGF,FGF-7） 株 NIBSC 1900
03/152 Anti-HPA-1a standard 株 NIBSC 1900
03/164 Anti-B minimum potency reference preparation 株 NIBSC 1900
03/178 Vitamin B12, Serum Folate 株 NIBSC 1900
03/182 Anti-Meningococcal Serotype P3.21 mAb 株 NIBSC 1900
03/188 Anti-A minimum potency reference preparation 株 NIBSC 1900
03/190 Anti-HPA-3a（minimum potency） 株 NIBSC 1900
03/192 Thyroid Stimulating Hormone, recombinant 株 NIBSC 1900
03/198 Influenza Virus infectious A/Kumamoto/102/02 株 NIBSC 1900
03/200 Interleukin – 18 （Human rDNA derived） 株 NIBSC 1900
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb 株 NIBSC 1900
03/212 Influenza anti A/Wyoming/03/03 Serum 株 NIBSC 1900
03/220 Influenza Antigen A/Wyoming/03/03 株 NIBSC 1900
03/224 Anti-Meningococcal Serosubtype P1.10 mAb 株 NIBSC 1900
03/226 Anti-Meningococcal Serosubtype P1.5 mAb 株 NIBSC 1900
03/228 Protein S, Plasma, Human 株 NIBSC 1900
03/236 Anti-Meningococcal Serosubtype P1.13 mAb 株 NIBSC 1900
03/242 Influenza anti A/Puerto Rico/8/34 （H1N1） HA Serum 株 NIBSC 1900
03/244 Influenza anti A/chick/Germany/N/49 （H10N7） HA Serum （sheep） 株 NIBSC 1900
03/258 Influenza Antigen A/New Caledonia/20/99 （IVR-116） 株 NIBSC 1900
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A Reference Panel 株 NIBSC 1900
03/B346-11 QCRHSV2QC1- Anti-HSV2 Quality Control Serum: Sample 1 株 NIBSC 1900
04/102 Blood Coagulation Factor XI Plasma, Human（1st I.S.） 株 NIBSC 1900
04/122 Anti-Meningococcal Serosubtype P1.12 mAb 株 NIBSC 1900
04/132 IVIG + Anti-D for use with negative control IVIG 株 NIBSC 1900
04/140 IVIG Negative Control for use with IVIG & Anti-D 株 NIBSC 1900
04/142 Methylated Human Serum Albumin 株 NIBSC 1900
04/160 Influenza Virus infectious NYMC X-147 株 NIBSC 1900
04/166 TNF-related Apoptosis-Inducing Ligand （trail）, Human, rDNA-derived 株 NIBSC 1900
04/170 Influenza Virus infectious A/Wellington/1/2004 株 NIBSC 1900
04/172 Influenza Virus infectious IVR-139 株 NIBSC 1900
04/198 Anti-Meningococcal Serotype P3.1 mAb 株 NIBSC 1900
04/200 Parathyroid hormone 1-34 Recombinant, Human 株 NIBSC 1900
04/202 Influenza Antigen B/ Jiangsu/10/2003 株 NIBSC 1900
04/214 Influenza anti A/Vietnam/1194/04 （NIBRG-14） HA Serum （sheep SH440&SH442） 株 NIBSC 1900
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 株 NIBSC 1900
04/228 Influenza anti B/ Neuraminidase Serum 株 NIBSC 1900
04/230 Influenza anti N1 Neuraminidase Serum 株 NIBSC 1900
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum （sheep） 株 NIBSC 1900
04/246 Anti-Meningococcal Serogroup W-135 mAb 株 NIBSC 1900
04/248 Anti-Meningococcal Serosubtype P1.19 mAb 株 NIBSC 1900
04/252 Protein C Concentrate, Human 株 NIBSC 1900
04/258 Influenza anti N2 Neuraminidase Serum（prepared from A/Wyoming/3/2003） 株 NIBSC 1900
04/260 Influenza anti A/New Caledonia/20/99 HA Serum （sheep） 株 NIBSC 1900
04/262 Influenza anti A/New York/55/2004 HA Serum （sheep） 株 NIBSC 1900
04/264 Influenza Antigen A/New York/55/2004 （H3N2） （NYMC X-157） 株 NIBSC 1900
05/102 Influenza Virus infectious NYMC BX-7 株 NIBSC 1900
05/106 Anti-HPA-1a minimum potency reagent 株 NIBSC 1900
05/110 Influenza Virus infectious A/California/7/2004 株 NIBSC 1900
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration （2nd International Standard）. 株 NIBSC 1900
05/122 Anti-syphilis plasma IgG （human） 株 NIBSC 1900
05/130 Prothrombin Mutation G20210A, Human gDNA, 1st International Genetic Reference Panel 2005 株 NIBSC 1900
05/132 Anti-syphilis plasma IgG and IgM （human） 株 NIBSC 1900
05/134 Anti-human papillomavirus type 16 serum （1st International Standard） 株 NIBSC 1900
05/138 Influenza Virus infectious B/Shanghai/361/2002 株 NIBSC 1900
05/162 Alpha-1-Antitrypsin, plasma derived 株 NIBSC 1900
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 株 NIBSC 1900
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody 株 NIBSC 1900
05/208-001 HLA-A Genotyping Reference Panel. 株 NIBSC 1900
05/232 Influenza Virus infectious A/Hiroshima/52/2005 株 NIBSC 1900
05/234 Influenza Antigen A/Wisconsin/67/2005 – Like 株 NIBSC 1900
05/236 Influenza anti A/Wisconsin/67/2005 Serum （sheep） 株 NIBSC 1900
05/242 IVIG, Anti-D and Negative Control Panel 株 NIBSC 1900
05/244 Influenza Virus infectious NYMC X-161 株 NIBSC 1900
05/248 Anti Dengue, WHO Reference Panel 株 NIBSC 1900
05/252 Influenza anti B Neuraminidase Serum （Sheep SH463） 株 NIBSC 1900
06/102 Hepatitis C Virus for Nucleic Acid Amplification Techniques （4th WHO International Standard） 株 NIBSC 1900
06/106 Influenza Antigen A/Wisconsin/67/2005 （H3N2） （NYMCX-161） 株 NIBSC 1900
06/108 Influenza Virus infectious IVR-116 株 NIBSC 1900
06/114 Influenza Virus Infectious A/PR/8/34 株 NIBSC 1900
06/124 Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 （1st International Standard） 株 NIBSC 1900
06/128 Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 （1st International Standard） 株 NIBSC 1900
06/140 Pertussis Antiserum （human）1st IS – WHO international Standard. 株 NIBSC 1900
06/142 Pertussis Antiserum （Human） 1st WHO Reference Reagent 株 NIBSC 1900
06/164 Influenza Virus infectious 1 VR-142 株 NIBSC 1900
06/166 Antithrombin Concentrate, Human 株 NIBSC 1900
06/170 Influenza Antigen A/New Caledonia/20/99 株 NIBSC 1900
06/172 FEIBA Concentrate 1st NIBSC Working Reference Standard 株 NIBSC 1900
06/184 Influenza Virus infectious A/Wisconsin/67/2005 株 NIBSC 1900
06/192 Influenza anti A/turkey/Turkey/1/05 （NIBRG-23） HA serum（sheepSH465 & SH466） 株 NIBSC 1900
06/202 HPV 16 DNA 株 NIBSC 1900
06/206 HPV 18 DNA 株 NIBSC 1900
06/210 Medium Titre Meningococcal OMV Ref. serum 株 NIBSC 1900
06/236 Influenza Virus infectious A/Solomon Islands/3/2006 07/132 株 NIBSC 1900
06/242 Influenza Virus infectious NYMC-X161 B 株 NIBSC 1900
06/B461-06 QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5 株 NIBSC 1900
06/B475-10 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 株 NIBSC 1900
07/102 Influenza Antigen A/Solomon Islands/3/2006 （IVR-145）（H1N1） 株 NIBSC 1900
07/104 Influenza anti A/Solomon Islands/3/2006 （H1N1） （IVR-145） HA Serum （sheep 467,468,469,470） 株 NIBSC 1900
07/112 Influenza Antigen A/turkey/Turkey/1/2005 （H5N1） NIBRG-23 株 NIBSC 1900
07/132 Influenza Virus infectious B/Malaysia/2506/2004 株 NIBSC 1900
07/144 Influenza Virus infectious IVR-145, 株 NIBSC 1900
07/146 Influenza anti A/HongKong/1073/99 like HA Serum （sheep） 株 NIBSC 1900
07/148 Influenza anti A/Vietnam/1194/04 （H5N1） HA Serum 株 NIBSC 1900
07/150 Human Plasma Anti-Influenza H5N1 株 NIBSC 1900
07/164 Anti-HBs immunoglobulin 株 NIBSC 1900
07/182 Blood Coagulation Factor IX Concentrate, Human, 4th International Standard” 株 NIBSC 1900
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum （sheep） 株 NIBSC 1900
07/202 Recombinant soluble transferrin receptor （rsTfR）（1st WHO Reference Reagent） 株 NIBSC 1900
07/214 Positive Control for use in flow cytometry cross matching （FCXM） and anti-HLA serology 株 NIBSC 1900
07/216 Diphtheria Toxoid （Adsorbed） （4th International Standard） 株 NIBSC 1900
07/222 RhD/SRY Plasma DNA sensitivity standard 株 NIBSC 1900
07/226 Influenza Virus Infectious A/New Caledonia/20/99 株 NIBSC 1900
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” 株 NIBSC 1900
07/246 Influenza Virus Infectious IVR-147 株 NIBSC 1900
07/252 Influenza Virus infectious NIBRG-14 株 NIBSC 1900
07/268 Influenza Virus Infectious B/Brisbane/3/2007 株 NIBSC 1900
07/270 BCG Vaccine of Danish 1331 sub-strain （1st WHO Reference Reagent） 株 NIBSC 1900
07/272 BCG Vaccine of Tokyo 172 sub-strain（1st WHO Reference Reagent） 株 NIBSC 1900
07/274 BCG Vaccine of Russian BCG-I sub-strain（1st WHO Reference Reagent） 株 NIBSC 1900
07/278 Influenza anti A/mallard/Netherlands/12/2000 （H7） HA serum （NIBRG-60） （sheep SH474 AND SH475） 株 NIBSC 1900
07/286-009 Hepatitis B Surface Antigen Monitor Sample 株 NIBSC 1900
07/288-008 Hepatitis B Surface Antigen 0.2IU/ml 株 NIBSC 1900
07/290 Influenza Antigen A/Anhui/1/05 （H5N1） IBCDC-RG-6 株 NIBSC 1900
07/294-003 Norovirus GII for Nucleic Acid Amplification Techniques 株 NIBSC 1900
07/296-003 Influenza Virus （A/Christchurch/1/2003, H1N1） for Nucleic Acid Amplification Techniques 株 NIBSC 1900
07/298-003 Influenza Virus （A/Wyoming/3/2003, H3N2） for Nucleic Acid Amplification Techniques 株 NIBSC 1900
07/300-004 Influenza Virus （B/Jiangsu/10/2003） for Nucleic Acid Amplification Techniques 株 NIBSC 1900
07/304 Anti-D for assuring operator and test performance 株 NIBSC 1900
07/306 Anti-A and Anti-B in IVIG Positive Control 株 NIBSC 1900
07/308 Anti-A and Anti-B in IVIG Negative Control 株 NIBSC 1900
07/310 Anti-A and anti-B in IVIG: Limit reference preparation 株 NIBSC 1900
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma （6th I.S.） 株 NIBSC 1900
07/318 Meningococcal Group C Polysaccharide 株 NIBSC 1900
07/326 Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. 株 NIBSC 1900
07/328 Unfractionated Heparin （6th I.S.） 株 NIBSC 1900
07/336 Influenza Antigen A/mallard/Netherlands/12/00 （H7N3） NIBRG-60 株 NIBSC 1900
07/338 Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （Sheep SH477） 株 NIBSC 1900
07/348 Influenza Virus infectious NYMC X-171B 株 NIBSC 1900
07/350 Blood Coagulation Factor VIII Concentrate （8th I.S.） 株 NIBSC 1900
07/354 Influenza Virus infectious A/Uruguay/716/2007 株 NIBSC 1900
07/358 Influenza Virus infectious NIB-50 株 NIBSC 1900
07/362 Influenza Virus infectious IVR-149 株 NIBSC 1900
07/364 Chorionic Gonadotrophin, （5th International Standard） 株 NIBSC 1900
07/B498-12 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 株 NIBSC 1900
07/B512-09 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 株 NIBSC 1900
08/100 Influenza Antigen A/Brisbane/59/2007 （IVR-148） （H1N1） 株 NIBSC 1900
08/108 Influenza Virus Infectious NIBRG-91 株 NIBSC 1900
08/110 Influenza Virus Infectious NIBRG-88 株 NIBSC 1900
08/114-004 Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/118-003 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/120-003 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/126 Influenza anti A/turkey/Turkey/1/05（N1） NA Serum （NIBRG-74） （Sheep SH485） 株 NIBSC 1900
08/138 Influenza Virus Infectious B/Florida/4/2006 株 NIBSC 1900
08/140 Influenza Antigen B/Florida/4/2006 株 NIBSC 1900
08/142 Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （sheep SH477） 株 NIBSC 1900
08/148 Positive control for Luminex based anti-HLA Class II serology 株 NIBSC 1900
08/150 HIV-2 RNA（1st International Standard） 株 NIBSC 1900
08/154 Influenza Virus Infectious NIBRG-12 株 NIBSC 1900
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3 株 NIBSC 1900
08/158 Fragile X Syndrome gDNA Genetic Reference Panel 株 NIBSC 1900
08/160 Haemophilia A, Intron-22 inversion, gDNA, Genetic Reference Panel 株 NIBSC 1900
08/174-003 Human Coxsackie B4 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/176-002 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/178-002 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/180-002 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/184 Influenza Antigen B/Malaysia/2506/2004 株 NIBSC 1900
08/202 Influenza anti A/chick/Hong Kong/G9/1997/（H9） HA serum （NIBRG-94）（H9N1） 株 NIBSC 1900
08/204 Thyroid Stimulating Antibody （2nd I.S.） 株 NIBSC 1900
08/208 Influenza Antigen Hong Kong/1073/99 （H9N2） 株 NIBSC 1900
08/210 Influenza anti A/Cambodia/R0405050/2007 （H5） HA serum （NIBRG-86） 株 NIBSC 1900
08/214 Neisseria meningitidis serogroup C polysaccharide （1st International Standard） 株 NIBSC 1900
08/216 Influenza Antigen A/Cambodia/R0405050/2007 （H5N1） NIBRG-88 株 NIBSC 1900
08/224-003 Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/226-003 Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 （H9N2） NIBRG-91 株 NIBSC 1900
08/230 Streptodornase （2nd International Standard） 株 NIBSC 1900
08/246 Influenza anti A/Brisbane/10/2007- like HA serum 株 NIBSC 1900
08/256 C1- Inhibitor, Concentrate （1st International Standard） 株 NIBSC 1900
08/258 Antithrombin, Plasma （3rd International Standard） 株 NIBSC 1900
08/262 C1 Inhibitor （Plasma）（1st International Standard） 株 NIBSC 1900
08/266 Sex Hormone Binding Globulin. （2nd International Standard） 株 NIBSC 1900
08/268 Influenza Antigen A/mallard/England/727/2006 （H2N3） NIBRG-107 株 NIBSC 1900
08/270 Anti-A and Anti-B in IVIG: Positive and Negative control panel. （2 ampoules of 07/306 and 2 ampoules of 07/308） 株 NIBSC 1900
08/278 Influenza Antigen A/Brisbane/10/2007-like （Prepared from A/Uruguay/716/2007 （NYMC X-175C）） 株 NIBSC 1900
08/280 Influenza Virus Infectious B/Brisbane/33/2008 株 NIBSC 1900
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay （2nd International Standard） 株 NIBSC 1900
08/300 Influenza Virus Infectious IVR-148 株 NIBSC 1900
08/304 Influenza virus infectious NYMC X-175C 株 NIBSC 1900
08/310-003 Varicella Zoster Virus （Type B） Working Reagent for Nucleic Acid Amplification Testing （NAT） 株 NIBSC 1900
08/314-004 Human Cytomegalovirus for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/316-003 Epstein-Barr Virus for Nucleic Acid Amplification Techniques 株 NIBSC 1900
08/318-003 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing 株 NIBSC 1900
08/320-002 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing 株 NIBSC 1900
08/322-002 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 株 NIBSC 1900
08/324-003 Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 株 NIBSC 1900
08/352 Influenza Antigen B/Brisbane/60/2008-like 株 NIBSC 1900
08/356 Influenza anti A/Japan/305/57 （H2） HA serum （A/Singapore/1/57-Like） （Sheep SH398） 株 NIBSC 1900
08/358 HIV-1RNA Genotype Panel 株 NIBSC 1900
08/362 Influenza Antigen A/New York/107/2003 （H7N2） NIBRG-109 株 NIBSC 1900
08/B531-10 QCRVZVQC1-Anti VZV:Quality Control Serum: Sample 1 株 NIBSC 1900
08/B534-05 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 株 NIBSC 1900
08/B536-14 QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 株 NIBSC 1900
08/B538-07 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 株 NIBSC 1900
08/B539-12 QCRNEGQC1-Negative Quality Control Serum: Sample1 株 NIBSC 1900
08/B554-09 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 株 NIBSC 1900
09/100 Influenza anti A/mallard/England/727/2006 （N3） NA serum （NIBRG-107） （Sheep SH503） 株 NIBSC 1900
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology（NAT） based assays Genotype Panel（1st International Standard） 株 NIBSC 1900
09/112 Negative Control for use in flow cytometry cross matching （FCXM） and anti-HLA serology 株 NIBSC 1900
09/130 Influenza Virus Infectious NIBRG-122 株 NIBSC 1900
09/132-002 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing 株 NIBSC 1900
09/136 Granulocyte Colony Stimulating Factor （Human, rDNA Derived）（2nd International Standard） 株 NIBSC 1900
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR （1st I.S.） 株 NIBSC 1900
09/140 Prader Willi & Angelman Syndromes, Human gDNA,（1st International Genetic Reference Panel） 株 NIBSC 1900
09/146 Influenza Antigen A/California/7/2009 （H1N1）v （NYMC-X179A） （Egg derived） 株 NIBSC 1900
09/148 Influenza anti A/New York/107/2003 （H7） HA serum （Sheep SH504 and SH505） 株 NIBSC 1900
09/154 Clostridium Sordellii anti-serum （1st International standard） 株 NIBSC 1900
09/162 Human Cytomegalovirus （HCMV） for Nucleic Acid Amplification Techniques （1st International Standard） 株 NIBSC 1900
09/170 Anti-Meningococcal factor H binding protein variant 1 （JAR4） monoclonal antibody 株 NIBSC 1900
09/172 Blood coagulation Factors II, VII, IX, X Plasma （4th International Standard） 株 NIBSC 1900
09/174 Influenza Antigen A/California/7/09 （H1N1）v （NYMCX-179A） （Cell Derived） 株 NIBSC 1900
09/182 VWF Factor Concentrate （2nd International Standard） 株 NIBSC 1900
09/184 Influenza Antigen A/Vietnam/1194/2004 （H5N1） NIBRG-14 株 NIBSC 1900
09/186 Anti-Chagas Disease （TcII） Ig in Human Plasma 株 NIBSC 1900
09/188 Anti-Chagas Disease （TcI） Ig in Human Plasma 株 NIBSC 1900
09/196 Influenza Antigen A/California/7/2009 （H1N1v） （NIBRG-121xp） （Egg Derived） 株 NIBSC 1900
09/222 Human reference Serum for Antibodies specific for Haemophilus Influenzae b Polysaccharide 株 NIBSC 1900
09/234 Transforming Growth Factor-BETA 3 （Human, rDNA derived TGF-ß 3） 株 NIBSC 1900
09/236 Influenza Virus Infectious IVR-153 株 NIBSC 1900
09/260 Epstein-Barr Virus （1st International Standard） 株 NIBSC 1900
09/264 Fibrinogen Plasma （D）（3rd International Standard） 株 NIBSC 1900
09/266 Glial cell line-derived neurotrophic factor, GDNF 株 NIBSC 1900
09/268 Influenza Virus Infectious NIBRG-121xp 株 NIBSC 1900
09/272 Placental Growth Factor 株 NIBSC 1900
09/274 Influenza Virus Infectious NYMC X-185 株 NIBSC 1900
09/276 Influenza Virus Infectious A/Brisbane/59/2007 株 NIBSC 1900
09/280 Influenza Virus Infectious NIB-64 株 NIBSC 1900
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent 株 NIBSC 1900
09/304 Influenza Virus Infectious IVR-155 株 NIBSC 1900
09/306 Influenza Virus Infectious NIBRG-147 株 NIBSC 1900
09/308 Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 （X179A） 株 NIBSC 1900
09/310 Influenza Antigen A/Wisconsin/15/09 （H3N2） （NYMCX-183） 株 NIBSC 1900
09/316 Influenza Anti B Neuraminidase Serum （B/Florida/4/2006） 株 NIBSC 1900
09/318 Influenza Virus Infectious NYMC BX-35 株 NIBSC 1900
09/B558-03 QCRHIV1RTDQC1-Anti-HIV1 Quality Control Serum: Sample1 for Rapid Test Devices 株 NIBSC 1900
09/B562-04 QCRHIV1QC3- Anti-HIV1:Quality Control Serum: Sample3 株 NIBSC 1900
09/B564-05 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 株 NIBSC 1900
09/B566-05 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2 株 NIBSC 1900
09/B571-05 QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 株 NIBSC 1900
09/B572-13 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 株 NIBSC 1900
09/B577-03 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 株 NIBSC 1900
09/B584-06 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 株 NIBSC 1900
09/B585-10 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 株 NIBSC 1900
09/B587-06 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1 株 NIBSC 1900
09/B588-02 QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1 株 NIBSC 1900
10/106 Influenza Antigen B/Brisbane/60/2008 Reassortant （NYMC BX-35） 株 NIBSC 1900
10/120 Influenza Antiserum A/Brisbane/59/2007 （H1N1）（IVR-148） HA （sheep 516 and 517） 株 NIBSC 1900
10/128 Diphtheria Polyclonal Antibody 株 NIBSC 1900
10/130 Diphtheria Monoclonal Antibody 株 NIBSC 1900
10/136-001 HLA-DRB1 Genotyping Reference Panel 株 NIBSC 1900
10/140 Anti-HPV 18 Serum 株 NIBSC 1900
10/142 Negative control for Luminex based anti-HLA serology 株 NIBSC 1900
10/150-004 Anti Hepatitis C Virus 株 NIBSC 1900
10/152 HIV-1 RNA （3rd International standard） 株 NIBSC 1900
10/154-002 Anti-HCV （1 in 8 dilution） 株 NIBSC 1900
10/188 Factor VIII Concentrate （13th British Standard）. 株 NIBSC 1900
10/202 Influenza antibody （Human） to A/California/7/2009 ‘like’ （H1N1v） virus 株 NIBSC 1900
10/214 Influenza Anti A/Hong Kong 1073/99 （N2）NA Serum （Sheep SH395 SH396） 株 NIBSC 1900
10/216 Influenza Virus Infectious NIB-74 株 NIBSC 1900
10/218 Influenza Anti A/California/7/2009 （N1） NA Serum （Sheep SH 521） 株 NIBSC 1900
10/226 Influenza Virus Infectious IVR-158 株 NIBSC 1900
10/232 Genomic DNA for blood group genotyping RBC1（AR1R1） 株 NIBSC 1900
10/234 Genomic DNA for blood group genotyping RBC12 （ODpsi） 株 NIBSC 1900
10/236 Genomic DNA for blood group genotyping RBC4（OR1R2） 株 NIBSC 1900
10/238 Genomic DNA for blood group genotyping RBC5（Brr） 株 NIBSC 1900
10/258 Influenza Antigen A/California/7/2009-like（NIB-74） 株 NIBSC 1900
10/262 Diphtheria Antitoxin Human IgG 株 NIBSC 1900
10/264 Hepatitis B Virus for Nucleic Acid Amplification Techniques （3rd WHO International Standard） 株 NIBSC 1900
10/272 BCG Substrain Moreau 株 NIBSC 1900
10/276 Influenza virus infectious BX-31 株 NIBSC 1900
10/276 Influenza virus infectious BX-31 株 NIBSC 1900
10/280 Anti-HLA Control 株 NIBSC 1900
10/286 Follicle Stimulating Hormone, Leutinizing Hormone human, urinary for bioassay 株 NIBSC 1900
10/B590-04 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 株 NIBSC 1900
10/B592-04 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 株 NIBSC 1900
10/B594-02 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 株 NIBSC 1900
10/B596-04 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 株 NIBSC 1900
10/B599-03 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1 株 NIBSC 1900
11/106 Influenza Virus infectious A/Perth/16/2009 株 NIBSC 1900
11/106 Influenza Virus infectious A/Perth/16/2009 株 NIBSC 1900
11/108 Influenza Virus infectious NYMC X-187 株 NIBSC 1900
11/108 Influenza Virus infectious NYMC X-187 株 NIBSC 1900
11/112 Influenza Virus infectious NYMC X-179A 株 NIBSC 1900
11/112 Influenza Virus infectious NYMC X-179A 株 NIBSC 1900
11/128 Influenza Virus Infectious NYMC X-181 株 NIBSC 1900
11/130 Influenza Virus Infectious NIBRG-14 株 NIBSC 1900
11/134 Influenza Antigen A/California/7/2009 （H1N1） Like （A/Brisbane/10/2010- cell derived） 株 NIBSC 1900
11/136 Influenza Anti-B/Brisbane/60/2008 HA Serum 株 NIBSC 1900
11/182-001 HBV DNA Working Reagent 株 NIBSC 1900
11/186 Influenza Virus infectious NIB-74xp 株 NIBSC 1900
11/200 Diphtheria Antitoxin Equine 株 NIBSC 1900
11/206 Influenza anti-A/Perth/16/2009 HA Serum 株 NIBSC 1900
11/208-001 Parvovirus B19 DNA 株 NIBSC 1900
11/214 Blood Group Genotyping Reference Panel 株 NIBSC 1900
11/216 Chagas Antibody Reference Panel （ 1st International Standard） 株 NIBSC 1900
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel 株 NIBSC 1900
11/222 Influenza Virus Infectious NIB-79 株 NIBSC 1900
11/226 Influenza Virus Infectious A/Victoria/361/2011 株 NIBSC 1900
11/232 Influenza Virus Infectious B/Texas/6/2011 株 NIBSC 1900
11/236 Factor XIa 株 NIBSC 1900
11/238 Influenza anti-A/California/7/2009 （H1N1） HA serum 株 NIBSC 1900
11/244 Influenza Virus Infectiious NYMC BX-49 株 NIBSC 1900
11/B601-02 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 株 NIBSC 1900
11/B603-02 QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 株 NIBSC 1900
11/B604-001 QCRFLUAH5QC1 Influenza H5 PC1 株 NIBSC 1900
12/100 Influenza Virus Infectious NYMC X-217 株 NIBSC 1900
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 （NYMCBX-39） 株 NIBSC 1900
12/110 Influenza Antigen B/Wisconsin/1/2010 （cell derived） 株 NIBSC 1900
12/112 Influenza Antigen A/Victoria/210/2009 （H3N2） （NYMCX-187） 株 NIBSC 1900
12/114 Influenza Antigen A/Victoria/361/2011 （H3N2） （IVR-165） 株 NIBSC 1900
12/116 Influenza anti-A/Victoria/361/2011-like HA serum 株 NIBSC 1900
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum 株 NIBSC 1900
12/122 Influenza virus infectious A/turkey/Italy/3889/1999 株 NIBSC 1900
12/168 Influenza Antigen A/California/7/09 （H1N1） （NYMCX-181） Egg derived 株 NIBSC 1900
12/174 Infectious Virus Influenza A/California/7/2009 株 NIBSC 1900
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5 株 NIBSC 1900
12/200 Influenza virus infectious B/Brisbane/60/2008 34500 E7 株 NIBSC 1900
12/202 Influenza virus infectious NYMC BX-39 株 NIBSC 1900
12/204 Influenza Virus infectious IVR-165 株 NIBSC 1900
2CPBETAAT Clostridium Perfringens Beta Antitoxin 株 NIBSC 1900
2CPEPSILONAT Clostridium Perfringens Epsilon Antitoxin 株 NIBSC 1900
59/015 Gas Gangrene （Cl. Perfringens（Cl. Welchii） Type A）, Equine 株 NIBSC 1900
59/016 Corticotrophin （ACTH）, Porcine 株 NIBSC 1900
59/021 Botulinum Antitoxin Equine Type A 株 NIBSC 1900
60/001 Botulinum Antitoxin Equine Type B 株 NIBSC 1900
60/013 Tetanus Antitoxin, Equine, for Bioassay 株 NIBSC 1900
61/001 Botulinum Antitoxin Equine Type D 株 NIBSC 1900
62/001 Serum Gonadotrophin, Equine 株 NIBSC 1900
62/014 Lysine Vasopressin, Porcine 株 NIBSC 1900
63/005 Gas Gangrene Antitoxin （Cl. Histolyticum）, Equine 株 NIBSC 1900
63/007 Diphtheria Antitoxin, Equine, for Flocculation Test 株 NIBSC 1900
64/002 Rheumatoid Arthritis Serum 株 NIBSC 1900
64/014 Gas Gangrene Antitoxin （Cl. Septicum）, Equine 株 NIBSC 1900
64/024 Gas Gangrene Antitoxin （Cl. Oedematiens）, Equine 株 NIBSC 1900
65/093 Anti-Thyroglobulin Serum, Human 株 NIBSC 1900
65/119 Renin, Porcine 株 NIBSC 1900
65/122 Long-acting Thyroid Stimulator, Human 株 NIBSC 1900
66/021 Tetanus Antitoxin, Equine, for Flocculation Test 株 NIBSC 1900
66/138 Gastrin II, Porcine 株 NIBSC 1900
66/153 Diphtheria Antitoxin, Equine 株 NIBSC 1900
66/233 Anti-Nuclear Factor Serum （Homogenous） Human 株 NIBSC 1900
66/304 Insulin, Human 株 NIBSC 1900
66/387 Anti-thyroid Microsome Serum, Human 株 NIBSC 1900
67/018 Interferon, Chick 株 NIBSC 1900
67/037 Immunoglobulin D （IgD） Serum, Human 株 NIBSC 1900
67/086 Immunoglobulins G, A, M Serum Human 株 NIBSC 1900
67/099 Immunoglobulins G, A & M Serum Human 株 NIBSC 1900
67/182 Anti-Rubella Serum, Human 株 NIBSC 1900
67/183 Primary Biliary Cirrhosis Serum, Human 株 NIBSC 1900
67/343 Erythropoietin, Human, Urinary 株 NIBSC 1900
68/340 Anti-Nucleolar Factor Plasma, Human 株 NIBSC 1900
68/356 Renin, Human 株 NIBSC 1900
69/017 Diphtheria Toxoid, Plain 株 NIBSC 1900
69/065 Autoimmune Antibody to Human Spermatazoa 株 NIBSC 1900
69/194 Glucagon, Porcine 株 NIBSC 1900
70/302 Angiotensin II 株 NIBSC 1900
71/328 Angiotensin I 株 NIBSC 1900
73/515 Anti-D （Rho） Antibodies, Human 株 NIBSC 1900
73/545 Placental Lactogen, Human 株 NIBSC 1900
73/601 Carcinoembryonic Antigen （CEA）, Human 株 NIBSC 1900
74/520 Serum Proteins （Other than Immunoglobulins） Human 株 NIBSC 1900
74/555 Corticotrophin （ACTH）, Human 株 NIBSC 1900
74/581 Ancrod 株 NIBSC 1900
74/586 Corticotrophin （ACTH）, Porcine 株 NIBSC 1900
75/506 Cocksfoot Pollen Extract 株 NIBSC 1900
75/533 Chorionic Gonadotrophin, Human, for Radioiodination 株 NIBSC 1900
75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination 株 NIBSC 1900
75/551 Chorionic Gonadotrophin beta Subunit, Human 株 NIBSC 1900
75/569 Chorionic Gonadotrophin alpha subunit, Human 株 NIBSC 1900
75/595 Blood Coagulation Factor Xa, Bovine 株 NIBSC 1900
76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 株 NIBSC 1900
76/515 Mannan （C. Albians） Purified 株 NIBSC 1900
76/522 Opacity 5IRP 株 NIBSC 1900
76/525 Anti-Birch Pollen Serum, Human 株 NIBSC 1900
76/547 Influenza anti A/Victoria/3/75 Serum（goat） 株 NIBSC 1900
76/575 Oxytocin 株 NIBSC 1900
76/589 Tetanus Antitoxin, Human, Immunoglobulin 株 NIBSC 1900
77/503 Anti-Cocksfoot Serum, Human 株 NIBSC 1900
77/512 Lysine Vasopressin 株 NIBSC 1900
77/530 Influenza Antigen A/New Jersey/8/76 株 NIBSC 1900
77/531 Influenza anti A/New Jersey/8/76 （H1N1） Serum（sheep） 株 NIBSC 1900
77/568 Influenza anti B/Hong Kong/8/73 Serum（sheep） 株 NIBSC 1900
77/584 Anti-D Pteronyssinus Serum, Human 株 NIBSC 1900
77/600 Mannan （C. Albicans） Purified 株 NIBSC 1900
77/616 Twelve Grass Pollen Extract 株 NIBSC 1900
77/643 Secretin 株 NIBSC 1900
77/662 Acarus Siro Extract 株 NIBSC 1900
77/664 Glycyphagus destructor Extract 株 NIBSC 1900
78/517 Tyrophagus Putrescentiae Extract 株 NIBSC 1900
78/543 Kininogenase, Porcine 株 NIBSC 1900
78/545 Anti-Aspergillus fumigatus Serum, Human 株 NIBSC 1900
78/554 Luteinizing Hormone, Pituitary, alpha subunit 株 NIBSC 1900
78/556 Luteinizing Hormone, Pituitary, beta subunit 株 NIBSC 1900
78/560 Influenza Antigen A/Texas/1/77 株 NIBSC 1900
78/569 Influenza anti A/Texas/1/77 Serum （sheep） 株 NIBSC 1900
78/575 Aspergillus Fumigatus Extract 株 NIBSC 1900
78/582 Tyrophagus Longior Extract 株 NIBSC 1900
78/628 Bee Venom 株 NIBSC 1900
79/500 Parathyroid Hormone, Human 株 NIBSC 1900
79/516 Influenza anti A/Brazil/11/78 Serum （goat） 株 NIBSC 1900
79/552 Influenza Antigen A/USSR/92/77 株 NIBSC 1900
79/558 Influenza Antigen A/USSR/92/77 株 NIBSC 1900
79/560 Influenza Antigen A/Brazil/11/78 株 NIBSC 1900
79/568 Influenza Antigen B/Hong Kong/8/73 株 NIBSC 1900
79/572 Prekallikrein Activator （PKA）, Human 株 NIBSC 1900
80/505 Growth Hormone, Human, Pituitary 株 NIBSC 1900
80/517 Influenza Antigen A/Bangkok/1/79 株 NIBSC 1900
80/519 Influenza Antigen B/Singapore/222/79 株 NIBSC 1900
80/523 Influenza anti B/Singapore/222/79 Serum 株 NIBSC 1900
80/525 Influenza anti A/Bangkok/1/79 Serum （sheep） 株 NIBSC 1900
80/552 Luteinizing Hormone, Human, Pituitary 株 NIBSC 1900
80/590 Tetracosactide 株 NIBSC 1900
81/565 Thyroid Stimulating Hormone, Human 株 NIBSC 1900
82/508 Parathyroid Hormone, Human-Type, Synthetic （1-34） fragment 株 NIBSC 1900
82/512 Parathyroid Hormone, Bovine-Type, Synthetic （1-34） fragment 株 NIBSC 1900
82/518 Dermatophagoides Pteronyssinus Extract 株 NIBSC 1900
82/520 Timothy Pollen Extract 株 NIBSC 1900
82/585 Anti Poliovirus serum types 1,2 and 3 株 NIBSC 1900
82/587 Interferon Gamma （Human, Leukocyte derived） 株 NIBSC 1900
82/632 Parathyroid Hormone, Bovine 株 NIBSC 1900
82/652 Human Serum Vitamin B12, Pernicous anaemia 株 NIBSC 1900
83/500 Insulin, Human 株 NIBSC 1900
83/501 Beta Thromboglobulin, Purified Human 株 NIBSC 1900
83/505 Plaet Factor 4 Human, Purified 株 NIBSC 1900
83/511 Insulin, Bovine 株 NIBSC 1900
83/514 Interferon alpha-1D, （Human rDNA derived） 株 NIBSC 1900
83/515 Insulin, Porcine 株 NIBSC 1900
83/537 Influenza Antigen A/Philippines/2/82 株 NIBSC 1900
83/545 Influenza anti A/Philippine/2/82 Serum （sheep） 株 NIBSC 1900
83/550 Influenza Antigen A/Brazil/11/78 株 NIBSC 1900
83/573 Prolactin, Human 株 NIBSC 1900
83/575 Follicle Stimulating Hormone, Pituitary 株 NIBSC 1900
84/500 Prolactin, Human 株 NIBSC 1900
84/510 C- Peptide of Human Insulin 株 NIBSC 1900
84/514 Proinsulin, Bovine 株 NIBSC 1900
84/522 Birch Pollen Extract 株 NIBSC 1900
84/528 Proinsulin, Porcine 株 NIBSC 1900
84/538 Influenza Antigen A/Chile/1/83 株 NIBSC 1900
84/542 Influenza Antigen B/Norway/1/84 株 NIBSC 1900
84/581 Short Ragweed Pollen Extract 株 NIBSC 1900
84/611 Proinsulin, Human 株 NIBSC 1900
84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue （Elcatonin） 株 NIBSC 1900
84/628 Anti-c Serum, Human 株 NIBSC 1900
84/636 Influenza anti B/USSR/100/83 Serum（sheep） 株 NIBSC 1900
84/640 Influenza anti A/Chile/1/8 Serum（sheep） 株 NIBSC 1900
84/673 Influenza anti A/equine/Prague/56 （H7N7） Serum（goat） 株 NIBSC 1900
84/677 Influenza anti A/equine/Miami/63 （H3N8） Serum（goat） 株 NIBSC 1900
84/685 Dog （Canis Familiaris） Hair Dander Extract 株 NIBSC 1900
85/506 C-Reactive Protein, Human 株 NIBSC 1900
85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum （sheep） 株 NIBSC 1900
85/520 Influenza Antigen A/Equine/Kentucky/1/81 株 NIBSC 1900
85/522 Thyroid Stimulating Hormone beta subunit 株 NIBSC 1900
85/551 Anti-Rye Grass Serum, Human 株 NIBSC 1900
85/553 Influenza Antigen A/Equine/Prague/56 （H7N7） 株 NIBSC 1900
85/616 Haemoglobin F Lysate, Raised 株 NIBSC 1900
85/669 Atrial Natriuretic Factor, Human 株 NIBSC 1900
86/504 Interleukin-2 （Human, Jurkat derived） 株 NIBSC 1900
86/536 Angiotensin I Human Type Synthetic 株 NIBSC 1900
86/538 Angiotensin II 株 NIBSC 1900
86/552 Interleukin-1 Beta （Human, rDNA derived） 株 NIBSC 1900
86/564 Interleukin-2 （Human, rDNA derived） 株 NIBSC 1900
86/576 Influenza Antigen A/Mississippi/1/85 株 NIBSC 1900
86/590 Influenza anti A/Mississippi/1/85 Serum（sheep） 株 NIBSC 1900
86/592 Influenza anti B/Ann Arbor/1/86/HA Serum （sheep） 株 NIBSC 1900
86/630 Influenza Antigen B/Ann Arbor/1/86 株 NIBSC 1900
86/632 Interleukin-1 alpha （Human rDNA derived） 株 NIBSC 1900
86/678 Interleukin-1 alpha （Human, rDNA derived） 株 NIBSC 1900
86/680 Interleukin-1 beta （Human, rDNA derived） 株 NIBSC 1900
86/690 Inhibin, Porcine 株 NIBSC 1900
87/510 Influenza Antigen A/Equine/Miami/63 株 NIBSC 1900
87/578 Influenza anti A/Leningrad/360/86 Serum （sheep） 株 NIBSC 1900
87/584 Influenza Antigen A/Leningrad/360/86 株 NIBSC 1900
87/586 Interferon Gamma （Human, rDNA derived） 株 NIBSC 1900
87/594 Urokinase, High Molecular Weight 株 NIBSC 1900
87/640 Tumour Necrosis Factor beta （Human, rDNA derived） 株 NIBSC 1900
87/654 Anti-Ferritin Monoclonal Antibody （1） 株 NIBSC 1900
87/662 Anti-Ferritin Monoclonal Antibody （2） 株 NIBSC 1900
87/690 Erythropoietin Human recDNA 株 NIBSC 1900
87/714 Influenza Antigen A/Sichuan/2/87 株 NIBSC 1900
87/774 Influenza Antigen B/Victoria/2/87 株 NIBSC 1900
88/522 Bordela pertussis （Whole cell vaccine） 3BRP 株 NIBSC 1900
88/532 Tumour Necrosis Factor alpha （Mouse, rDNA derived） 株 NIBSC 1900
88/554 Influenza Antigen B/Beijing/7/87 株 NIBSC 1900
88/556 Calcitonin, Eel 株 NIBSC 1900
88/638 Thyroxine-binding globulin 株 NIBSC 1900
88/646 Granulocyte Macrophage Colony Stimulating Factor （Human, rDNA derived） 株 NIBSC 1900
88/654 Influenza Antigen A/England/427/88 株 NIBSC 1900
88/656 Interleukin-4 （Human, rDNA derived） 株 NIBSC 1900
88/672 Influenza anti A/Sichuan/2/87 Serum（sheep） 株 NIBSC 1900
88/678 Influenza anti B/Beijing/1/87 Serum（sheep） 株 NIBSC 1900
88/786 Tumour Necrosis Factor alpha （Human Natural） 株 NIBSC 1900
88/846 Influenza anti A/England/427/88 Serum（sheep） 株 NIBSC 1900
89/512 Macrophage Colony Stimulating Factor （CSF-1） （Human rDNA derived） 株 NIBSC 1900
89/514 Transforming Growth Factor beta-1 （Human, rDNA derived） 株 NIBSC 1900
89/516 Transforming Growth Factor beta-1 （Bovine） 株 NIBSC 1900
89/518 Transforming Growth Factor beta-2 （Bovine） 株 NIBSC 1900
89/520 Interleukin-8 （Human, rDNA derived） 株 NIBSC 1900
89/530 Anti-Bordela pertussis serum （Human） 株 NIBSC 1900
89/544 Renin, Human, rec DNA 株 NIBSC 1900
89/548 Interleukin-6 （Human, rDNA derived） 株 NIBSC 1900
89/568 Influenza Antigen A/OMS/5389/88 株 NIBSC 1900
89/594 Bordela pertussis （W28） LPS 2ug 株 NIBSC 1900
89/596 Bordela pertussis anti-agglutinogen 1（rabbit） 株 NIBSC 1900
89/598 Bordela pertussis anti-agglutinogen 2 （rabbit） 株 NIBSC 1900
89/600 Bordela pertussis anti-agglutinogen 3 （rabbit） 株 NIBSC 1900
89/620 Calcitonin, Human 株 NIBSC 1900
89/666 Haemoglobin A2 Lysate, Raised 株 NIBSC 1900
89/670 Bordela pertussis （W28） LPS25ug 株 NIBSC 1900
90/500 Influenza Antigen A/Shanghai/16/89 株 NIBSC 1900
90/502 Influenza Antigen A/Guizhou/54/89 株 NIBSC 1900
90/504 Influenza anti A/Guangdong/39/89 Serum（sheep） 株 NIBSC 1900
90/520 Bordela pertussis, filamentous haemagglutinin （FHA） 株 NIBSC 1900
90/530 Interleukin-7 （Human, rDNA derived） 株 NIBSC 1900
90/534 Mumps Vaccine （Live） 株 NIBSC 1900
90/586 Interleukin-5 （Human, rDNA derived） 株 NIBSC 1900
90/636 HIV-1 P24 Antigen 株 NIBSC 1900
90/654 Bordela pertussis 69kD 株 NIBSC 1900
90/690 Anti-Varicella-Zoster Antibody 株 NIBSC 1900
90/696 Transforming Growth Factor beta-2, Human, rec DNA 株 NIBSC 1900
90/712 Basic Fibroblast Growth Factor （Human, rDNA derived） 株 NIBSC 1900
90/784 Influenza Virus infectious NIB-26 （H3N2） 株 NIBSC 1900
91/510 Interleukin-3 （Human, rDNA derived） 株 NIBSC 1900
91/530 Epidermal Growth Factor （Human, rDNA derived） 株 NIBSC 1900
91/550 Epidermal Growth Factor （1-52） （Human, rDNA derived） 株 NIBSC 1900
91/554 Insulin-like growth Factor 1 株 NIBSC 1900
91/562 Anti-D for use with papain preparation 92/658 株 NIBSC 1900
91/612 Influenza anti A/Taiwan/1/86 Serum （sheep） 株 NIBSC 1900
91/624 Inhibin A, Human, recombinant 株 NIBSC 1900
91/626 Activin A, Human, Recombinant 株 NIBSC 1900
91/656 Interleukin-4 （Mouse, rDNA derived） 株 NIBSC 1900
91/658 Granulocyte Macrophage Colony Stimulating Factor （Mouse rDNA derived） 株 NIBSC 1900
91/660 Influenza Virus infectious A/Texas/36/91 （H1N1） 株 NIBSC 1900
91/662 Interleukin-3 （Mouse, rDNA derived） 株 NIBSC 1900
91/670 Influenza Virus infectious NIB-27 （H1N1） 株 NIBSC 1900
91/678 Interleukin-9 （Human,rDNA derived） 株 NIBSC 1900
91/682 Stem Cell Factor （Human rDNA derived） 株 NIBSC 1900
91/688 Rubella Vaccine （Live） 株 NIBSC 1900
92/510 Follicle Stimulating Hormone, Human, recombinant 株 NIBSC 1900
92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary 株 NIBSC 1900
92/518 Macrophage Inflammatory Protein-1 alpha （Human, rDNA derived） 株 NIBSC 1900
92/520 Rantes （Human, rDNA derived） 株 NIBSC 1900
92/530 Influenza Antigen A/Texas/36/91 株 NIBSC 1900
92/582 Influenza anti B/Yamagata/16/88 Serum（sheep） 株 NIBSC 1900
92/628 Influenza Antigen B/Yamagata/16/88 株 NIBSC 1900
92/632 Influenza anti A/Beijing/352/89 （H3N2） Serum （sheep） 株 NIBSC 1900
92/644 Interleukin-1 Receptor Antagonist （IL-1ra） （Human, rDNA derived） 株 NIBSC 1900
92/648 Measles Vaccine （Live） 株 NIBSC 1900
92/654 Plasminogen Activator Inhibitor-1 （PAI-1）, plasma Human 株 NIBSC 1900
92/658 Papain preparation for use with Anti-D preparation 91/562 株 NIBSC 1900
92/680 Serum amyloid A protein 株 NIBSC 1900
92/734 Influenza Virus infectious A/Beijing/32/92 （H3N2） 株 NIBSC 1900
92/738 Influenza Virus infectious A/Shanghai/24/90 株 NIBSC 1900
92/788 Interleukin-11 （Human, rDNA derived） 株 NIBSC 1900
92/794 Monocyte Chemoattractant Protein-1 （Human,rDNA derived） 株 NIBSC 1900
93/500 Influenza Antigen A/Beijing/32/92 株 NIBSC 1900
93/516 Influenza Antigen A/Shanghai/24/90 株 NIBSC 1900
93/518 Influenza anti A/Beijing/32/92 （H3N2） Serum （sheep） 株 NIBSC 1900
93/522 Influenza anti A/Shanghai/24/90 （H3N2） Serum （sheep） 株 NIBSC 1900
93/524 Soluble Tumor Necrosis Receptor factor Type II （Human, rDNA derived） 株 NIBSC 1900
93/526 Batroxobin 株 NIBSC 1900
93/556 Nerve Growth Factor （Human, rDNA derived） 株 NIBSC 1900
93/560 Insulin-like growth Factor Binding Protein-3 株 NIBSC 1900
93/562 Leukaemia Inhibitory Factor （Human, rDNA derived） 株 NIBSC 1900
93/564 Oncostatin M （Human, rDNA derived） 株 NIBSC 1900
93/566 Interleukin-2 （Mouse, rDNA derived） 株 NIBSC 1900
93/568 Influenza Virus infectious A/Beijing/359/89 （H3N2） 株 NIBSC 1900
93/572 Influenza Virus infectious A/Guizhou/54/89 （H3N2） 株 NIBSC 1900
93/574 Bone morphogenetic Protein-2 （Human, rDNA derived） 株 NIBSC 1900
93/668 Interleukin-1 beta （Mouse, rDNA derived） 株 NIBSC 1900
93/672 Interleukin-1 alpha （Mouse, rDNA derived） 株 NIBSC 1900
93/686 Influenza Virus infectious A/Shangdong/9/93 （H3N2） 株 NIBSC 1900
93/692 Influenza Virus infectious B/Panama/45/90 株 NIBSC 1900
93/722 Interleukin-10 （Human rDNA derived） 株 NIBSC 1900
93/730 Interleukin-6 （Mouse, rDNA derived） 株 NIBSC 1900
93/740 Interleukin-7 （Mouse, rDNA derived） 株 NIBSC 1900
93/816 Influenza Virus infectious A/Harbin/15/92 （H3N2） 株 NIBSC 1900
94/500 Influenza Antigen B/Panama/45/90 株 NIBSC 1900
94/504 Influenza anti A/Shanghai/9/93 Serum（sheep） 株 NIBSC 1900
94/516 Influenza Antigen A/Shangdong/9/93 株 NIBSC 1900
94/520 Influenza anti B/Panama/45/90 Serum（sheep） 株 NIBSC 1900
94/532 Pertussis Vaccine Whole Cell 株 NIBSC 1900
94/572 Ferritin, Human, recombinant 株 NIBSC 1900
94/622 Interleukin-13 （Human, rDNA derived） 株 NIBSC 1900
94/674 Thyroid Stimulating Hormone, Human recombinant 株 NIBSC 1900
94/684 Ciliary Neurotrophic Factor （Human, rDNA derived） 株 NIBSC 1900
94/718 Straphylokinase, rec （STAR） 株 NIBSC 1900
94/728 Plaet-derived Growth Factor-BB （Human, rDNA derived） 株 NIBSC 1900
94/730 Tissue Plasminogen Activator （tPA） Antigen in Plasma 株 NIBSC 1900
94/754 Interferon Omega （Human, rDNA derived） 株 NIBSC 1900
94/758 Influenza Virus infectious A/Johannesburg/33/94 （H3N2） 株 NIBSC 1900
94/760 Influenza Virus infectious B/Beijing/184/93 株 NIBSC 1900
94/762 Influenza Virus infectious RESVIR-8 （H3N2） 株 NIBSC 1900
94/766 Influenza Virus infectious NIB-34 （H3N2） 株 NIBSC 1900
94/784 Interferon alpha （Human, leukocyte derived） 株 NIBSC 1900
94/786 Interferon alpha Concensus Sequence （Human rDNA derived） 株 NIBSC 1900
94/790 MAPREC analysis of Poliovirus type 3 （Sabin）. Synthetic DNA 100% 472-C 株 NIBSC 1900
95/510 Influenza Antigen A/Texas/36/91 株 NIBSC 1900
95/516 Influenza Antigen A/Johannesburg/33/94 株 NIBSC 1900
95/522 Anti-HBc （Anti-hepatitis B core antigen） 株 NIBSC 1900
95/524 Influenza anti A/Johannesburg/33/94 Serum（sheep） 株 NIBSC 1900
95/528 Folate, Whole Blood Haemolysate 株 NIBSC 1900
95/542 MAPREC analysis of Poliovirus type 3 （Sabin） Synthetic DNA 0.9% 472-C 株 NIBSC 1900
95/544 Interleukin-12 （Human, rDNA derived） 株 NIBSC 1900
95/554 Interleukin-15 （Human, rDNA derived） 株 NIBSC 1900
95/564 Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Non-Glyc） 株 NIBSC 1900
95/566 Interferon alpha-2b （Human, rDNA derived） 株 NIBSC 1900
95/568 Interferon Alpha n1 （Human lymphoblastoid cell derived） 株 NIBSC 1900
95/572 Interferon alpha-1/8 （Human, rDNA derived） 株 NIBSC 1900
95/574 Interferon Alpha n3 （Human, leukocyte derived） 株 NIBSC 1900
95/580 Interferon alpha-2c （Human, rDNA derived） 株 NIBSC 1900
95/584 Anti-hepatitis E Serum, Human 株 NIBSC 1900
95/646 Parathyroid Hormone 1-84, human, recombinant（1st International Standard） 株 NIBSC 1900
95/650 Interferon alpha-2a （Human, rDNA derived） 株 NIBSC 1900
95/668 Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Glyc） 株 NIBSC 1900
95/674 Anti-Meningococcal Serogroup A mAb 株 NIBSC 1900
95/678 Anti-Meningococcal Serogroup C mAb 株 NIBSC 1900
95/758 Influenza Virus infectious A/Wuhan/359/95 （H3N2） 株 NIBSC 1900
96/528 Soluble Tumour Necrosis Factor Receptor Type 1, （Human, rDNA derived） 株 NIBSC 1900
96/532 FMS-like tyrosine kinase 3 ligand （Human, rDNA derived） 株 NIBSC 1900
96/534 Brain-derived Neurotrophic Factor （Human, rDNA derived） 株 NIBSC 1900
96/538 Insulin-like growth Factor-II （Human rDNA derived） 株 NIBSC 1900
96/556 Hepatocyte Growth Factor/Scatter Factor （precursor）, （Human rDNA derived） 株 NIBSC 1900
96/564 Hepatocyte Growth Factor/Scatter Factor （Human, rDNA derived） 株 NIBSC 1900
96/572 MAPREC analysis of Poliovirus type 3 （Sabin） Low virus reference 0.7%472-C 株 NIBSC 1900
96/578 MAPREC analysis of Poliovirus type 3 （Sabin） High virus reference 1.1%472-C 株 NIBSC 1900
96/602 Luteinizing Hormone, Human, recombinant 株 NIBSC 1900
96/666 Anti-Human Globulin 株 NIBSC 1900
96/668 Prostate Specific Antigen （free） 株 NIBSC 1900
96/670 Prostate Specific Antigen （90:10） 株 NIBSC 1900
96/784 Inhibin B, Human 株 NIBSC 1900
96/830 Influenza Virus infectious A/Bayern/7/95 株 NIBSC 1900
96/836 Influenza Virus infectious RESVIR-9 （H3N2） 株 NIBSC 1900
96/848 Influenza Virus infectious A/Shenzhen/227/95 （H1N1） 株 NIBSC 1900
96/850 Influenza Virus infectious NIB-39 （H1N1） 株 NIBSC 1900
97/518 Influenza Antigen A/Johannesburg/82/96 株 NIBSC 1900
97/536 Plasmin, Human 株 NIBSC 1900
97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 株 NIBSC 1900
97/550 Islet Cell Antibodies 株 NIBSC 1900
97/558 Bordela pertussis anti 69kD serum （sheep） 株 NIBSC 1900
97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant（1st I.S.） 株 NIBSC 1900
97/564 Bordela pertussis anti FHA serum （sheep） 株 NIBSC 1900
97/572 Bordela pertussis PT anti serum （sheep） 株 NIBSC 1900
97/574 Bordela pertussis anti Fim3 serum （sheep） 株 NIBSC 1900
97/584 Influenza Antigen A/Equine/Newmarket/2/93 株 NIBSC 1900
97/592 Blood Coagulation Factor VII Concentrate（1st I.S.） 株 NIBSC 1900
97/594 Leptin, Human, Recombinant 株 NIBSC 1900
97/596 Influenza Antigen A/Equine/Newmarket/1/93 株 NIBSC 1900
97/600 Interleukin-2 Soluble Receptor （human, rDNA derived） 株 NIBSC 1900
97/610 Influenza anti A/equine/Newmarket/1/93 Serum（sheep） 株 NIBSC 1900
97/612 Influenza anti A/Nanchang/933/95 （H3N2） 株 NIBSC 1900
97/614 Influenza anti A/Equine/Newmarket/2/93 （H3N8） HA Serum （SH-376） 株 NIBSC 1900
97/626 Leptin, Mouse, Recombinant 株 NIBSC 1900
97/642 Bordela pertussis anti serum （mouse） 1RR 株 NIBSC 1900
97/646 Anti-Hepatitis A Immunoglobulin, Human （W1041） 株 NIBSC 1900
97/648 Anti-Measles serum 株 NIBSC 1900
97/662 AntiStreptolysin O 株 NIBSC 1900
97/692 Influenza Virus infectious IVR-108 （H3N2） 株 NIBSC 1900
97/714 Prolactin, Human, recombinant 株 NIBSC 1900
97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 （H5N3） 株 NIBSC 1900
97/726 Influenza Virus infectious B/Harbin/7/94 株 NIBSC 1900
97/748 Influenza Antigen B/Harbin/7/94 株 NIBSC 1900
97/756 MAPREC analysis of Poliovirus type 2 （Sabin）, low virus reference 0.65%481-G 株 NIBSC 1900
97/758 MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA 0.67%481-G 株 NIBSC 1900
97/760 Influenza Antigen A/Beijing/262/95 株 NIBSC 1900
98/524 MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA, 100%481-G 株 NIBSC 1900
98/544 Influenza Virus infectious RESVIR-13 （H3N2） 株 NIBSC 1900
98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 株 NIBSC 1900
98/574 Somatropin 株 NIBSC 1900
98/580 Prolactin Human, recombinant, glycosylated 株 NIBSC 1900
98/582 Prolactin, Human, recombinant, non-glycosylated 株 NIBSC 1900
98/586 Calcitonin, Salmon 株 NIBSC 1900
98/590 Blood Coagulation Factors II and X Concentrate（3rd I.S.） 株 NIBSC 1900
98/596 MAPREC analysis of Poliovirus type 2 （Sabin）, high virus reference 1.21% 481-G 株 NIBSC 1900
98/600 Influenza Virus infectious NIB-40 （H5N3） 株 NIBSC 1900
98/604 Influenza anti B/Harbin/7/94/HA Serum （sheep） 株 NIBSC 1900
98/608 Transforming Growth Factor beta-3 （Human, rDNA derived） 株 NIBSC 1900
98/610 Influenza Virus infectious ARIV-1 （H5N3） 株 NIBSC 1900
98/614 Fibrinogen Concentrate, Human, 1st International Standard 株 NIBSC 1900
98/666 Influenza anti A/Hong Kong/489/97 （H5N1） Serum （sheep） 株 NIBSC 1900
98/686 Control Guinea Pig Serum 株 NIBSC 1900
98/708 Haemiglobincyanide 株 NIBSC 1900
98/714 Tissue Plasminogen Activator, Human, Recombinant 株 NIBSC 1900
98/718 Neurotrophin 3 株 NIBSC 1900
98/722 Meningococcal group A polysaccharide 株 NIBSC 1900
98/762 Influenza Virus infectious Resvir-14 （H3N2） 株 NIBSC 1900
98/772 Influenza anti A/Beijing/262/95 Serum （sheep） 株 NIBSC 1900
98/774 Influenza Antigen B/Shangdong/7/97 株 NIBSC 1900
98/778 Influenza Virus infectious A/Sichuan/346/98 （H3N2） 株 NIBSC 1900
99/506 Anti-PT S1 subunit Monoclonal Antibody （1B7） 株 NIBSC 1900
99/508 Anti-PT S1 subunit Monoclonal Antibody （1D7） 株 NIBSC 1900
99/510 Anti-PT S1 subunit Monoclonal Antibody （3F11） 株 NIBSC 1900
99/512 Anti-PT S1 subunit Monoclonal Antibody （10D6） 株 NIBSC 1900
99/514 Anti-PT S1 subunit Monoclonal Antibody （8G4） 株 NIBSC 1900
99/516 Anti-PT S1 subunit Monoclonal Antibody （E1E） 株 NIBSC 1900
99/518 Anti-PT S1 subunit Monoclonal Antibody （E2E） 株 NIBSC 1900
99/520 Anti-PT S1 subunit Monoclonal Antibody （3F10） 株 NIBSC 1900
99/522 Anti-PT S1 subunit Monoclonal Antibody （11D9） 株 NIBSC 1900
99/524 Anti-PT S1 subunit Monoclonal Antibody （4D10） 株 NIBSC 1900
99/526 Anti-PT S23 subunit Monoclonal Antibody （11E6） 株 NIBSC 1900
99/528 Anti-PT S23 subunit Monoclonal Antibody （10C9） 株 NIBSC 1900
99/530 Anti-PT S23 subunit Monoclonal Antibody （10B5） 株 NIBSC 1900
99/532 Anti-PT S23 subunit Monoclonal Antibody （G9A） 株 NIBSC 1900
99/534 Anti-PT S23 subunit Monoclonal Antibody （3F6） 株 NIBSC 1900
99/536 Anti-PT S2 subunit Monoclonal Antibody （3A12） 株 NIBSC 1900
99/538 Anti-PT S2 subunit Monoclonal Antibody （2H3） 株 NIBSC 1900
99/540 Anti-PT S2 subunit Monoclonal Antibody （9G8） 株 NIBSC 1900
99/542 Anti-PT S3 subunit Monoclonal Antibody （7E10） 株 NIBSC 1900
99/544 Anti-PT S3 subunit Monoclonal Antibody （7G11） 株 NIBSC 1900
99/546 Anti-PT S3 subunit Monoclonal Antibody （4G5） 株 NIBSC 1900
99/548 Anti-PT S3 subunit Monoclonal Antibody （2E12） 株 NIBSC 1900
99/550 Anti-PT S3 subunit Monoclonal Antibody （6F8） 株 NIBSC 1900
99/554 Anti-PT S4 subunit Monoclonal Antibody （7F2） 株 NIBSC 1900
99/556 Anti-PT S4 subunit Monoclonal Antibody （6B3） 株 NIBSC 1900
99/558 Anti-PT S4 subunit Monoclonal Antibody （6G8） 株 NIBSC 1900
99/560 Anti-PT S4 subunit Monoclonal Antibody （9F3） 株 NIBSC 1900
99/562 Anti-PT S4 subunit Monoclonal Antibody （1H2） 株 NIBSC 1900
99/564 Anti-PT S4 subunit Monoclonal Antibody （9C6） 株 NIBSC 1900
99/566 Anti-PT S4 subunit Monoclonal Antibody （6D6） 株 NIBSC 1900
99/568 Anti-PT S5 subunit Monoclonal Antibody （7E3） 株 NIBSC 1900
99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody （1C6） 株 NIBSC 1900
99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody （2E9） 株 NIBSC 1900
99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody （12G10） 株 NIBSC 1900
99/586 Influenza Antigen B/Yamanashi/166/98 株 NIBSC 1900
99/614 Influenza Antigen A/Sydney/5/97 株 NIBSC 1900
99/616 Yellow Fever Vaccine 株 NIBSC 1900
99/624 Influenza Antigen A/Sydney/5/97 株 NIBSC 1900
99/634-006 HIV-1 RNA Working Reagent 1 （PWS-1） for NAT Assays 株 NIBSC 1900
99/636-005 HIV-1 RNA Working Reagent 2 for NAT assays 株 NIBSC 1900
99/642 Chorionic Gonadotrophin, nicked, human 株 NIBSC 1900
99/650 Chorionic Gonadotrophin, beta subunit, human 株 NIBSC 1900
99/666 Anti-HPA-5b （Minimum Potency） 株 NIBSC 1900
99/674-012 HIV-2 （antibody） Monitor Sample 株 NIBSC 1900
99/688 Chorionic Gonadatrophin, intact, Human 株 NIBSC 1900
99/692 Chorionic Gonadotrophin, nicked beta subunit, Human 株 NIBSC 1900
99/698 Biotinylated Brad-5 （Bio-Brad-5） 株 NIBSC 1900
99/706 Anti-Meningococcal human reference serum CDC1992 株 NIBSC 1900
99/708 Chorionic Gonadatrophin, beta core fragment, Human 株 NIBSC 1900
99/710-015 HIV-1 （antibody） （1 in 5 dilution） British Working Standard 株 NIBSC 1900
99/714 Influenza Antigen A/Singapore/1/57 （H2N2） 株 NIBSC 1900
99/720 Chorionic Gonadotrophin, alpha subunit, Human （purified） 株 NIBSC 1900
99/728 Anti-D Immunoglobulin Control 株 NIBSC 1900
99/732 Multiplex Working Reagent （HCV, HBV, HAV, HIV, B19） 株 NIBSC 1900
99/750-017 HIV-1 （antibody） British Working Standard） 株 NIBSC 1900
99/774 Biotinylated Brad-5 株 NIBSC 1900
99/802 B19 DNA NAT assays.2nd I.S. 株 NIBSC 1900
99/824 Influenza Virus infectious RESVIR 16 （H3N2） 株 NIBSC 1900
99/828 Influenza Antigen B/Yamanashi/166/98 株 NIBSC 1900
99/836 Anti-D Minimum Potency Standard for blood grouping reagents 株 NIBSC 1900
AFP Alpha-Foetoprotein 株 NIBSC 1900
B2M Beta-2 Microglobulin 株 NIBSC 1900
BUSB Botulinum Antitoxin Equine Type B 株 NIBSC 1900
CDS Anti-Canine Distemper Serum 株 NIBSC 1900
CHAN Cholera Antitoxin, Goat 株 NIBSC 1900
CHS Anti-Canine Hepatitis Serum 株 NIBSC 1900
COT Clostridium novyi （alpha） Toxoid 株 NIBSC 1900
CWBETATD Clostridium Welchii （Perfringens）（Beta） Toxoid CwBT 株 NIBSC 1900
CWEPSILONTD Clostridium Welchii （Perfringens）（ Epsilon） Toxoid CwDT 株 NIBSC 1900
DY Anti-Dysentery （shiga） serum, Equine 株 NIBSC 1900
ECHS Anti-Echinococcus Serum, Human 株 NIBSC 1900
JNIH-11 Bordela pertussis anti FHA serum （mouse） 株 NIBSC 1900
JNIH-12 Bordela pertussis PT（ LPF） anti serum, （mouse） 株 NIBSC 1900
JNIH-3 Acellular Pertussis Vaccine – 1st IS 株 NIBSC 1900
JNIH-4 Bordela pertussis filamentous haemagglutinin （FHA） 株 NIBSC 1900
JNIH-5 Bordela pertussis toxin （PT） 1st IS 株 NIBSC 1900
MGDS Anti-Mycoplasma gallisepticum Serum 株 NIBSC 1900
NDS Anti-Newcastle Disease Serum 株 NIBSC 1900
NVIA Newcastle Disease Vaccine （Inactivated） 株 NIBSC 1900
OE Gas Gangrene Antitoxin （Cl. novyi）, Equine 株 NIBSC 1900
PE Gas Gangrene Antitoxin （Cl. Perfringens alpha antitoxin） Equine 株 NIBSC 1900
PPDA Purified Protein Derivative （PPD） of M Avium Tuberculin 株 NIBSC 1900
PPDBOV Purified Protein Derivative （PPD） of Bovine Tuberculin 株 NIBSC 1900
PPDT Purified Protein Derivative （PPD） of M. Tuberculosis Tuberculin 株 NIBSC 1900
QF Anti-Q Fever Serum, Bovine 株 NIBSC 1900
RAI Anti-rabies Immunoglobulin, Human 株 NIBSC 1900
RBT/05 Thromboplastin,rabbit,plain（pack of 5 ampoules） with diluent （pack of 5 04/210） 株 NIBSC 1900
RTF/09 Thromboplastin, Human Recombinant, Plain （4th I.S.） （Panel of 5 ampoules for use with 5 diluent 08/146）. 株 NIBSC 1900
RUBI-1-94 Anti-rubella Immunoglobulin, Human 株 NIBSC 1900
SES Swine Erysipelas Serum （anti-N） 株 NIBSC 1900
SFS Anti-Swine Fever Serum 株 NIBSC 1900
SMV Smallpox Vaccine 株 NIBSC 1900
SPDS-S2 Anti-Salmonella Pullorum Serum （Std. Form S） 株 NIBSC 1900
SPDS-V Anti-Salmonella Pullorum Serum （Variant Form V） 株 NIBSC 1900
SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine 株 NIBSC 1900
SSCLOT4 SSC/ISTH Secondary Coagulation Standard Lot#4 株 NIBSC 1900
STA Staphylococcus Alpha Antitoxin, Equine 株 NIBSC 1900
STT Diphtheria （Schick） Test Toxin 株 NIBSC 1900
TE-3 Tetanus Immunoglobulin, Human 株 NIBSC 1900
TILI Anti-tick borne encephalitis serum 株 NIBSC 1900
TISA Anti-tick borne encephalitis serum 株 NIBSC 1900
VI Gas Gangrene Antitoxin （Cl. Septicum）, Equine 株 NIBSC 1900
W1004 Anti-C complete blood typing serum,human 株 NIBSC 1900
W1005 Anti-E complete blood typing serum, human 株 NIBSC 1900
W1007 Anti-c Incomplete blood typing serum, human 株 NIBSC 1900
W1044 Anti-Varicella zoster immunoglobulin 株 NIBSC 1900
W1062 Anti smooth muscle（anti actin） autoantibody. 株 NIBSC 1900
W1063 Anti nuclear ribonucleoprotein（nRNP） autoantibody 株 NIBSC 1900
W1064 Anti-Nuclear factor serum,homogenous（66/233） 株 NIBSC 1900
W1066 Rheumatoid Arthritis serum. 株 NIBSC 1900
YF Anti-Yellow Fever Serum, monkey 株 NIBSC 1900
 

NIBSC 隶属 于NBSB, NBSB通过对 NIBSC 的管理，确保生物产 品的质量与安全，从而保障并促进公众的健康。 ＮＩＢＳＣ 提供对投入英国市场的生物药品的独立测 试，尤其是用于英国儿童免疫计划的疫苗；它同时 也是欧盟控制药品进入欧盟市场的官.方药品控制 实 验 室 （Official Medicines Control Laboratories, OMCL）。 如果出现不能满足药品存放要求或患者 出现不良反应等问题，NIBSC也可对已投入欧盟市 场的产品进行检验。 NIBSC制备的菌毒种和检测 抗原、抗血清标准品，保障了各厂家顺利的研究和 生产。

NIBSC常卖产品

NIBSC 代理

详细介绍

产品咨询

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心

NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的*。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

NIBSC供应的主要产品：

NIBSC提供生物医学研究领域大量的标准、参照品及试剂，包括WHO标准、流感试剂、质控试剂及其他欧盟认证的体外诊断试剂。在NIBSC的在线目录中，可以采购到所有生物制品参照材料、流感试剂及体外诊断产品。此外，NIBSC还供应AIDS试剂中心提供的超过6000种研究试剂，资源中心供应的Creutzfeldt-Jakob病评估、诊断及研究试剂。在细胞生物学研究领域，NIBSC还提供包括人类胚胎干细胞及其他干细胞等多种细胞株，用于科学研究及疾病疫苗测试。该系列主要产品包括：

一、标准生物制剂：该系列产品包括大量细胞因子/生长因子（如神经营养因子、各型白介素与干扰素、GDNF、VEGF）、内毒素、免疫球蛋白与免疫血清、蛋白激素及内分泌因子、大量诊断试剂及疫苗、干细胞株等。详细产品目录请访问：http://www.nibsc。。ｏｒｇ/products/brm_product_catalogue/sub_category_listing.aspx?category=Biotherapeutics&subcategory=Cytokines+and+Growth+Factors

二、AIDS中心供应的产品

NIBSC的CFAR是由医学研究协会资助下创建于1989年的HIV/AIDS试剂中心，是世界上仅有的的两个之一（欧洲*）致力于提供全部HIV/AIDS研究用试剂的研究中心。该中心目前供应的产品超过6000种，主要包括：各种HIV/AIDS研究用细胞株、病毒家系、DNA克隆、单/多克隆抗体、多肽、重组蛋白、细胞因子、趋化因子、抗HIV药物/复合物。

三、流感资源中心供应的产品

过去30年里，NIBSC 的流感资源中心在流感疫苗的生产与标准化中起着重要作用，流感疫苗研发与生产的关键问题在于流感病毒有着*的突变率，用于疫苗研发与生产的病毒株每隔一段时间须得更新，在WHO推荐用于疫苗生产和研发的流感病毒株选择上起着关键性作用。目前该中心为客户提供大量候选的流感疫苗、病毒、SRD试剂及唾液酸苷酶试剂。包括H1N1、H3N2、B (Yamagata lineage)、 B (Victoria lineage)。

四、CJD研究与资源中心供应的产品

NIBSC的CJD研究与资源中心成立于2001，致力于研究与生产CJD鉴定试剂、探索在使用重组的prion蛋白作为培养基质的血样中TSE感染的标志物检测中如何放大检测结果的方法。同时为研究人员供应一系列CJD鉴定及研究用相关试剂及实验方法。

五、英国干细胞库供应的产品

英国干细胞库 (UKSCB) 供应多种人/鼠全能/多能干细胞株及相关干细胞研究产品与研究方法与资料。

六、病毒研究用质控血清

NIBSC供应大量病毒研究用质控血清，目录随时更新，详见公司。

更多产品信息请访问：http://www.nibsc。。ｏｒｇ/

世界*实验材料供应商NIBSC上海金畔生物为其中国代理，NIBSC在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

NIBSC中国代理，NIBSC上海代理，NIBSC北京代理，NIBSC广东代理，NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理, NIBSC江苏代理, NIBSC浙江代理, NIBSC四川代理,

我们公司zui大优势是强大的采购，

1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，

2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，

3：提供加急服务，一般1-2周到货，超过时限加急费全免

4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.

5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司

6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, NIBSC, Inc.  Genebridege; NIBSC Biotechnology GmbH; iduron; NIBSC； NIBSC； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;……几十家国外公司代理

7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend….等*批发

世界*实验材料供应商  NIBSC上海金畔生物为其中国代理，  NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

  NIBSC中国代理,  NIBSC上海代理，  NIBSC北京代理， NIBSC广东代理，  NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理,  NIBSC江苏代理,  NIBSC浙江代理,  NIBSC四川代理,

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心
NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

世界*实验材料供应商  NIBSC上海金畔生物为其中国代理，  NIBSC在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  NIBSC就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

  NIBSC中国代理,  NIBSC上海代理，  NIBSC北京代理， NIBSC广东代理，  NIBSC江苏代理 NIBSC湖北代理, NIBSC天津, NIBSC黑龙江代理, NIBSC内蒙古代理, NIBSC吉林代理, NIBSC福建代理,  NIBSC江苏代理,  NIBSC浙江代理,  NIBSC四川代理,

NIBSC——欧洲标准生物制剂、疫苗、细胞株供应中心
NIBSC（英国生物标准品研究所）是英国药品及卫生保健产品管理机构的枢纽与执行机构，英国生物医药检验实验室，主要的WHO生物制品标准实验室及WHO负责脊髓灰质炎、流感及HIV研究的协作中心，英国干细胞库，同时也是生物药制剂鉴定及其标准对照品生产供应的。NIBSC处于一个位于产品制造、调节、政策制定及学术前沿的*位置，通过提供生物制剂标准参照品、生物制剂鉴定及相关研究确保生物医药制品的质量，同时也为生物医药产品的研发提供有力支持。

NIBSC标准品产品代理

详细介绍

产品咨询

　英国国家生物制品检定所（National Institute for Biological Standards and Control，NIBSC）

　　英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。

　　NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的*药品控制实验室（OMCL）。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。

　　NIBSC认为对 NIBSC工作的核心职能制定并维护一项既均衡而又主次分明的计划至关重要。控制和评估生物药品。开发和提供关键的生物学标准和其它参考资料。开展针对任务的研究和开发工作。

Streptokinase 00/464
Interferon Beta （Human, rDNA; CHO cell-derived; Glycosylated） 00/572
Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated 00/574
Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated 00/576
Interleukin-17 Human rec DNA 01/420
Vascular Endothelial Growth Factor, Human rDNA derived 01/424
Botulinum Antitoxin Equine Type D 01/510
Anti-D Immunoglobulin 01/572
Thrombin, human, 2nd International Standard 01/580
Low Molecular Weight Heparin, 2nd International Standard 01/608
Blood Coagulation Factor VIII Concentrate, Human 02/122
Prekallikrein Activator （PKA）, Human 02/168
Blood Coagulation Factor XIII, Plasma, Human 1st IS 02/206
IVIG negative control for use with IVIG + anti-D 02/226
IVIG + anti-D for use with negative control IVIG 02/228
Vascular Endothelial Growth Factor 02/286
Blood Coagulation Factor V, Plasma（1st I.S.） 03/116
Thrombopoietin, human rDNA derived 03/124
Keratinocyte growth factor （KGF, FGF-7）（24-163） 03/148
Keratinocyte Growth Factor （KGF,FGF-7） 03/150
Thyroid Stimulating Hormone, recombinant 03/192
Interleukin – 18 （Human rDNA derived） 03/200
IVIG + Anti-D for use with negative control IVIG 04/132
IVIG Negative Control for use with IVIG & Anti-D 04/140
TNF-related Apoptosis-Inducing Ligand （trail）, Human, rDNA-derived 04/166
Parathyroid hormone 1-34 Recombinant, Human 04/200
Protein C Concentrate, Human 04/252
Low Molecular Weight Heparin for Molecular Weight Calibration （2nd International Standard）. 05/112
Alpha-1-Antitrypsin, plasma derived 05/162
IVIG, Anti-D and Negative Control Panel 05/242
Antithrombin Concentrate, Human 06/166
FEIBA Concentrate 1st NIBSC Working Reference Standard 06/172
Blood Coagulation Factor IX Concentrate, Human, 4th International Standard” 07/182
Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” 07/228
Anti-D for assuring operator and test performance 07/304
Anti-A and Anti-B in IVIG Positive Control 07/306
Anti-A and Anti-B in IVIG Negative Control 07/308
Anti-A and anti-B in IVIG: Limit reference preparation 07/310
Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma （6th I.S.） 07/316
Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. 07/326
Unfractionated Heparin （6th I.S.） 07/328
Blood Coagulation Factor VIII Concentrate （8th I.S.） 07/350
Chorionic Gonadotrophin, （5th International Standard） 07/364
Streptodornase （2nd International Standard） 08/230
C1- Inhibitor, Concentrate （1st International Standard） 08/256
Anti-A and Anti-B in IVIG: Positive and Negative control panel. （2 ampoules of 07/306 and 2 ampoules of 07/308） 08/270
Follicle-Stimulating Hormone, human, recombinant, for bioassay （2nd International Standard） 08/282
Granulocyte Colony Stimulating Factor （Human, rDNA Derived）（2nd International Standard） 09/136
VWF Factor Concentrate （2nd International Standard） 09/182
Corticotrophin （ACTH）, Porcine 59/016
Serum Gonadotrophin, Equine 62/001
Lysine Vasopressin, Porcine 62/014
Renin, Porcine 65/119
Gastrin II, Porcine 66/138
Interferon, Chick 67/018
Renin, Human 68/356
Glucagon, Porcine 69/194
Angiotensin II 70/302
Angiotensin I 71/328
Corticotrophin （ACTH）, Human 74/555
Ancrod 74/581
Blood Coagulation Factor Xa, Bovine 75/595
Oxytocin 76/575
Lysine Vasopressin 77/512
Secretin 77/643
Kininogenase, Porcine 78/543
Luteinizing Hormone, Pituitary, alpha subunit 78/554
Luteinizing Hormone, Pituitary, beta subunit 78/556
Prekallikrein Activator （PKA）, Human 79/572
Growth Hormone, Human, Pituitary 80/505
Luteinizing Hormone, Human, Pituitary 80/552
Tetracosactide 80/590
Parathyroid Hormone, Human-Type, Synthetic （1-34） fragment 82/508
Parathyroid Hormone, Bovine-Type, Synthetic （1-34） fragment 82/512
Interferon Gamma （Human, Leukocyte derived） 82/587
Parathyroid Hormone, Bovine 82/632
Insulin, Human 83/500
Beta Thromboglobulin, Purified Human 83/501
Plaet Factor 4 Human, Purified 83/505
Insulin, Bovine 83/511
Interferon alpha-1D, （Human rDNA derived） 83/514
Insulin, Porcine 83/515
Prolactin, Human 83/573
Follicle Stimulating Hormone, Pituitary 83/575
Prolactin, Human 84/500
Calcitonin, ASU 1-7 Eel Calcitonin Analogue （Elcatonin） 84/614
C-Reactive Protein, Human 85/506
Atrial Natriuretic Factor, Human 85/669
Interleukin-2 （Human, Jurkat derived） 86/504
Angiotensin I Human Type Synthetic 86/536
Angiotensin II 86/538
Interleukin-1 Beta （Human, rDNA derived） 86/552
Interleukin-2 （Human, rDNA derived） 86/564
Interleukin-1 alpha （Human rDNA derived） 86/632
Interleukin-1 alpha （Human, rDNA derived） 86/678
Interleukin-1 beta （Human, rDNA derived） 86/680
Inhibin, Porcine 86/690
Interferon Gamma （Human, rDNA derived） 87/586
Urokinase, High Molecular Weight 87/594
Tumour Necrosis Factor beta （Human, rDNA derived） 87/640
Tumour Necrosis Factor alpha （Mouse, rDNA derived） 88/532
Calcitonin, Eel 88/556
Erythropoietin, Human recombinant 88/574
Granulocyte Macrophage Colony Stimulating Factor （Human, rDNA derived） 88/646
Interleukin-4 （Human, rDNA derived） 88/656
Tumour Necrosis Factor alpha （Human Natural） 88/786
Macrophage Colony Stimulating Factor （CSF-1） （Human rDNA derived） 89/512
Transforming Growth Factor beta-1 （Human, rDNA derived） 89/514
Transforming Growth Factor beta-1 （Bovine） 89/516
Transforming Growth Factor beta-2 （Bovine） 89/518
Interleukin-8 （Human, rDNA derived） 89/520
Renin, Human, rec DNA 89/544
Interleukin-6 （Human, rDNA derived） 89/548
Calcitonin, Human 89/620
Interleukin-7 （Human, rDNA derived） 90/530
Interleukin-5 （Human, rDNA derived） 90/586
Transforming Growth Factor beta-2, Human, rec DNA 90/696
Basic Fibroblast Growth Factor （Human, rDNA derived） 90/712
Interleukin-3 （Human, rDNA derived） 91/510
Epidermal Growth Factor （Human, rDNA derived） 91/530
Epidermal Growth Factor （1-52） （Human, rDNA derived） 91/550
Insulin-like growth Factor 1 91/554
Inhibin A, Human, recombinant 91/624
Activin A, Human, Recombinant 91/626
Interleukin-4 （Mouse, rDNA derived） 91/656
Granulocyte Macrophage Colony Stimulating Factor （Mouse rDNA derived） 91/658
Interleukin-3 （Mouse, rDNA derived） 91/662
Interleukin-9 （Human,rDNA derived） 91/678
Stem Cell Factor （Human rDNA derived） 91/682
Follicle Stimulating Hormone, Human, recombinant 92/510
Follicle Stimulating Hormone, urofollitropin Human Urinary 92/512
Macrophage Inflammatory Protein-1 alpha （Human, rDNA derived） 92/518
Rantes （Human, rDNA derived） 92/520
Interleukin-1 Receptor Antagonist （IL-1ra） （Human, rDNA derived） 92/644
Plasminogen Activator Inhibitor-1 （PAI-1）, plasma Human 92/654
Serum amyloid A protein 92/680
Interleukin-11 （Human, rDNA derived） 92/788
Monocyte Chemoattractant Protein-1 （Human,rDNA derived） 92/794
Soluble Tumor Necrosis Receptor factor Type II （Human, rDNA derived） 93/524
Batroxobin 93/526
Nerve Growth Factor （Human, rDNA derived） 93/556
Leukaemia Inhibitory Factor （Human, rDNA derived） 93/562
Oncostatin M （Human, rDNA derived） 93/564
Interleukin-2 （Mouse, rDNA derived） 93/566
Bone morphogenetic Protein-2 （Human, rDNA derived） 93/574
Interleukin-1 beta （Mouse, rDNA derived） 93/668
Interleukin-1 alpha （Mouse, rDNA derived） 93/672
Interleukin-10 （Human rDNA derived） 93/722
Interleukin-6 （Mouse, rDNA derived） 93/730
Interleukin-7 （Mouse, rDNA derived） 93/740
Endotoxin 94/580
Interleukin-13 （Human, rDNA derived） 94/622
Ciliary Neurotrophic Factor （Human, rDNA derived） 94/684
Straphylokinase, rec （STAR） 94/718
Plaet-derived Growth Factor-BB （Human, rDNA derived） 94/728
Tissue Plasminogen Activator （tPA） Antigen in Plasma 94/730
Interferon Omega （Human, rDNA derived） 94/754
Interferon alpha （Human, leukocyte derived） 94/784
Interferon alpha Concensus Sequence （Human rDNA derived） 94/786
Interleukin-12 （Human, rDNA derived） 95/544
Interleukin-15 （Human, rDNA derived） 95/554
Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Non-Glyc） 95/564
Interferon alpha-2b （Human, rDNA derived） 95/566
Interferon Alpha n1 （Human lymphoblastoid cell derived） 95/568
Interferon alpha-1/8 （Human, rDNA derived） 95/572
Interferon Alpha n3 （Human, leukocyte derived） 95/574
Interferon alpha-2c （Human, rDNA derived） 95/580
Interferon alpha-2a （Human, rDNA derived） 95/650
Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Glyc） 95/668
Soluble Tumour Necrosis Factor Receptor Type 1, （Human, rDNA derived） 96/528
FMS-like tyrosine kinase 3 ligand （Human, rDNA derived） 96/532
Brain-derived Neurotrophic Factor （Human, rDNA derived） 96/534
Insulin-like growth Factor-II （Human rDNA derived） 96/538
Hepatocyte Growth Factor/Scatter Factor （precursor）, （Human rDNA derived） 96/556
Hepatocyte Growth Factor/Scatter Factor （Human, rDNA derived） 96/564
Luteinizing Hormone, Human, recombinant 96/602
Inhibin B, Human 96/784
Plasmin, Human 97/536
Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 97/538
Blood Coagulation Factors IXa Concentrate, Human, recombinant（1st I.S.） 97/562
Blood Coagulation Factor VII Concentrate（1st I.S.） 97/592
Leptin, Human, Recombinant 97/594
Interleukin-2 Soluble Receptor （human, rDNA derived） 97/600
Leptin, Mouse, Recombinant 97/626
Somatropin 98/574
Calcitonin, Salmon 98/586
Blood Coagulation Factors II and X Concentrate（3rd I.S.） 98/590
Transforming Growth Factor beta-3 （Human, rDNA derived） 98/608
Fibrinogen, Plasma, Human, 2nd IS 98/612
Fibrinogen Concentrate, Human, 1st International Standard 98/614
Follicle Stimulating Hormone and Luteinizing Hormone, Human Urinary 98/704
Tissue Plasminogen Activator, Human, Recombinant 98/714
Neurotrophin 3 98/718
Biotinylated Brad-5 （Bio-Brad-5） 99/698
Anti-D Immunoglobulin Control 99/728
Biotinylated Brad-5 99/774
Thromboplastin,rabbit,plain（pack of 5 ampoules） with diluent （pack of 5 04/210） RBT/05
Thromboplastin, Human Recombinant, Plain （4th I.S.） （Panel of 5 ampoules for use with 5 diluent 08/146）. RTF/09

Diagnostics
Hepatitis A Virus RNA NAT Assays 00/560
Hepatitis B Surface Antigen （HBsAg） subtype adw2, genotype A 00/588
Hepatitis A Virus RNA Working Reagent for NAT assays 01/488
Anti-Toxoplasma IgG, Human 01/600
Anti-Parvovirus B19, plasma, human 01/602
HIV （antibody）, 1st International Reference Panel 02/210
Insulin-like growth Factor I 02/254
HCV RNA Working Reagent for Nucleic Acid Amplification Techniques 02/264-003
Protein C Plasma 02/342
HTLV-1 （antibody） Monitor Sample 03/104-009
Anti-HPA-1a standard 03/152
Anti-B minimum potency reference preparation 03/164
Vitamin B12, Serum Folate 03/178
Anti-A minimum potency reference preparation 03/188
Anti-HPA-3a（minimum potency） 03/190
Protein S, Plasma, Human 03/228
Hepatitis B Surface Antigen subtype adw2, genotype A Reference Panel 03/262
QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample1 03/B346-06
Blood Coagulation Factor XI Plasma, Human（1st I.S.） 04/102
Plasmodium falciparum DNA for NAT Assays 04/176
Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 04/224
Anti-HPA-1a minimum potency reagent 05/106
Anti-syphilis plasma IgG （human） 05/122
Prothrombin Mutation G20210A, Human gDNA, 1st International Genetic Reference Panel 2005 05/130
Anti-syphilis plasma IgG and IgM （human） 05/132
HIV-1 RNA Working Reagent 3 for NAT Assays 05/158-002
HLA-A Genotyping Reference Panel. 05/208-001
QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1 05/B433-06
Hepatitis C Virus （HCV） RNA 06/100
Anti Hepatitis C Virus 06/188-006
Anti-HCV （1 in 8 dilution） 06/190-008
HPV 16 DNA 06/202
HPV 18 DNA 06/206
QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5 06/B461-04
QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 06/B475-06
Anti-HBs immunoglobulin 07/164
Recombinant soluble transferrin receptor （rsTfR）（1st WHO Reference Reagent） 07/202
Positive control for FCXM 07/214
RhD/SRY Plasma DNA sensitivity standard 07/222
Hepatitis B Surface Antigen Monitor Sample 07/286-006
Hepatitis B Surface Antigen 0.2IU/ml 07/288-004
Norovirus GII for Nucleic Acid Amplification Techniques 07/294-001
Influenza Virus （A/Christchurch/1/2003, H1N1） for Nucleic Acid Amplification Techniques 07/296-001
Influenza Virus （A/Wyoming/3/2003, H3N2） for Nucleic Acid Amplification Techniques 07/298-001
Influenza Virus （B/Jiangsu/10/2003） for Nucleic Acid Amplification Techniques 07/300-001
QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 07/B498-08
QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample1 07/B506-09
QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 07/B506-11
QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 07/B512-06
QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 07/B515-06
QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 07/B519-12
Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques 08/114-001
Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques 08/118-001
Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques 08/120-001
HIV-2 RNA（1st International Standard） 08/150
Fragile X Syndrome gDNA Genetic Reference Panel 08/158
Haemophilia A, Intron-22 inversion, gDNA, Genetic Reference Panel 08/160
Human Coxsackie B4 for Nucleic Acid Amplification Techniques 08/174-001
Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques 08/176-001
Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 08/178-001
Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques 08/180-001
Thyroid Stimulating Antibody （2nd I.S.） 08/204
Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques 08/224-001
Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques 08/226-001
Antithrombin, Plasma （3rd International Standard） 08/258
C1 Inhibitor （Plasma）（1st International Standard） 08/262
HCV RNA Genotype Panel for Nucleic acid amplification techniques 08/264
Sex Hormone Binding Globulin. （2nd International Standard） 08/266
Varicella Zoster Virus （Type B） Working Reagent for Nucleic Acid Amplification Testing （NAT） 08/310-001
Human Cytomegalovirus for Nucleic Acid Amplification Techniques 08/314-002
Epstein-Barr Virus for Nucleic Acid Amplification Techniques 08/316-001
Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing 08/318-001
Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing 08/320-001
Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 08/322-001
Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 08/324-001
HIV-1RNA Genotype Panel 08/358
QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 08/B523-03
QCRVZVQC1-AntiVZV: Quality Control Serum: Sample1 08/B531-06
QCRHIV2QC3-Anti HIV2: Quality Control Serum: Sample3 08/B534-03
QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 08/B536-05
QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 08/B538-04
QCRNEGQC1-Negative Quality Control Serum: Sample1 08/B539-06
QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 08/B542-06
QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 08/B544-06
QCRCMVQC1-Anti CMV: Quality Control Serum: Sample1 08/B549-06
QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 08/B554-04
Parvovirus B19 DNA Nucleic Acid Amplification Technology（NAT） based assays Genotype Panel（1st International Standard） 09/110
Negative Control for FCXM 09/112
Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing 09/132-001
Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR （1st I.S.） 09/138
Prader Willi & Angelman Syndromes, Human gDNA,（1st International Genetic Reference Panel） 09/140
Human Cytomegalovirus （HCMV） for Nucleic Acid Amplification Techniques （1st International Standard） 09/162
Blood coagulation Factors II, VII, IX, X Plasma （4th International Standard） 09/172
Neisseria meningitidis for Nucleic Acid Amplification Testing （NAT） 09/320-001
QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 09/B559-06
QCRHIV1QC3- Anti-HIV1:Quality Control Serum: Sample3 09/B562-01
QCRHBsGQC1-Anti HBsAg Quality Control Serum: Sample1 09/B564-02
QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 09/B566-01
QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 09/B571-02
QCRHAVIgMQC2-Anti-HAV Quality Control Serum: Sample2 09/B572-05
QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 09/B577-01
QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 09/B584-01
QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 09/B585-03
QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 09/B587-02
HBV DNA PCR Reference 10/194-001
Rheumatoid Arthritis Serum 64/002
Anti-Thyroglobulin Serum, Human 65/093
Long-acting Thyroid Stimulator, Human 65/122
Anti-Nuclear Factor Serum （Homogenous） Human 66/233
Insulin, Human 66/304
Anti-thyroid Microsome Serum, Human 66/387
Immunoglobulin D （IgD） Serum, Human 67/037
Immunoglobulins G, A, M Serum Human 67/086
Immunoglobulins G, A & M Serum Human 67/099
Primary Biliary Cirrhosis Serum, Human 67/183
Erythropoietin, Human, Urinary 67/343
Anti-Nucleolar Factor Plasma, Human 68/340
Autoimmune Antibody to Human Spermatazoa 69/065
Anti-D （Rho） Antibodies, Human 73/515
Placental Lactogen, Human 73/545
Carcinoembryonic Antigen （CEA）, Human 73/601
Serum Proteins （Other than Immunoglobulins） Human 74/520
Corticotrophin （ACTH）, Porcine 74/586
Serum Immunoglobulin E （IgE） Human 75/502
Cocksfoot Pollen Extract 75/506
Chorionic Gonadotrophin, Human, for Radioiodination 75/533
Chorionic Gonadotrophin beta, Human, for Radioiodination 75/535
Parathyroid Hormone, Human 75/549
Chorionic Gonadotrophin beta Subunit, Human 75/551
Chorionic Gonadotrophin alpha subunit, Human 75/569
Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 76/508
Mannan （C. Albians） Purified 76/515
Anti-Birch Pollen Serum, Human 76/525
Anti-Cocksfoot Serum, Human 77/503
Anti-D Pteronyssinus Serum, Human 77/584
Mannan （C. Albicans） Purified 77/600
Twelve Grass Pollen Extract 77/616
Acarus Siro Extract 77/662
Glycyphagus destructor Extract 77/664
Tyrophagus Putrescentiae Extract 78/517
Anti-Aspergillus fumigatus Serum, Human 78/545
Aspergillus Fumigatus Extract 78/575
Tyrophagus Longior Extract 78/582
Bee Venom 78/628
Parathyroid Hormone, Human 79/500
Anti-Cat Fur Serum, Human 79/530
Thyroid Stimulating Hormone, Human 81/565
Dermatophagoides Pteronyssinus Extract 82/518
Timothy Pollen Extract 82/520
Human Serum Vitamin B12, Pernicous anaemia 82/652
C- Peptide of Human Insulin 84/510
Proinsulin, Bovine 84/514
Birch Pollen Extract 84/522
Proinsulin, Porcine 84/528
Short Ragweed Pollen Extract 84/581
Proinsulin, Human 84/611
Anti-c Serum, Human 84/628
Dog （Canis Familiaris） Hair Dander Extract 84/685
Thyroid Stimulating Hormone beta subunit 85/522
Anti-Rye Grass Serum, Human 85/551
Haemoglobin F Lysate, Raised 85/616
Anti-Ferritin Monoclonal Antibody （1） 87/654
Anti-Ferritin Monoclonal Antibody （2） 87/662
Thyroxine-binding globulin 88/638
Haemoglobin A2 Lysate, Raised 89/666
HIV-1 P24 Antigen 90/636
Anti-Varicella-Zoster Antibody 90/690
Anti-D for use with papain preparation 92/658 91/562
Papain preparation for use with Anti-D preparation 91/562 92/658
Insulin-like growth Factor Binding Protein-3 93/560
Ferritin, Human, recombinant 94/572
Follicle Stimulating Hormone/Luteinizing Hormone, Human Pituitary 94/632
Thyroid Stimulating Hormone, Human recombinant 94/674
Anti-HBc （Anti-hepatitis B core antigen） 95/522
Folate, Whole Blood 95/528
Anti-hepatitis E Serum, Human 95/584
Parathyroid Hormone 1-84, human, recombinant（1st International Standard） 95/646
Lupus Anticoagulant Negative Control 96/522
Anti-Human Globulin 96/666
Prostate Specific Antigen （free） 96/668
Prostate Specific Antigen （90:10） 96/670
Islet Cell Antibodies 97/550
Anti-Hepatitis A Immunoglobulin, Human （W1041） 97/646
HIV-1 RNA, 2nd International Standard 97/650
Prolactin, Human, recombinant 97/714
Hepatitis B Virus DNA for nucleic acid amplification techniques 97/750
Prolactin Human, recombinant, glycosylated 98/580
Prolactin, Human, recombinant, non-glycosylated 98/582
Haemiglobincyanide 98/708
HIV-1 RNA Working Reagent 1 （PWS-1） for NAT Assays 99/634-005
HIV-1 RNA Working Reagent 2 for NAT assays 99/636-005
Chorionic Gonadotrophin, nicked, human 99/642
Chorionic Gonadotrophin, beta subunit, human 99/650
Anti-HPA-5b （Minimum Potency） 99/666
HIV-2 （antibody） Monitor Sample 99/674-010
Chorionic Gonadatrophin, intact, Human 99/688
Chorionic Gonadotrophin, nicked beta subunit, Human 99/692
Chorionic Gonadatrophin, beta core fragment, Human 99/708
HIV-1 （antibody） （1 in 5 dilution） British Working Standard 99/710-012
Chorionic Gonadotrophin, alpha subunit, Human （purified） 99/720
Multiplex Working Reagent （HCV, HBV, HAV, HIV, B19） 99/732
Parvovirus B19 DNA Working reagent 99/736
HIV-1 （antibody） British Working Standard） 99/750-013
B19 DNA NAT assays.2nd I.S. 99/802
Anti-D Minimum Potency Standard for blood grouping reagents 99/836
Alpha-Foetoprotein AFP
Beta-2 Microglobulin B2M
Anti-Canine Distemper Serum CDS
Cholera Antitoxin, Goat CHAN
Anti-Canine Hepatitis Serum CHS
Anti-Dysentery （shiga） serum, Equine DY
Anti-Echinococcus Serum, Human ECHS
Anti-Mycoplasma gallisepticum Serum MGDS
Anti-Newcastle Disease Serum NDS
Anti-Q Fever Serum, Bovine QF
Anti-rabies Immunoglobulin, Human RAI
Swine Erysipelas Serum （anti-N） SES
Anti-Swine Fever Serum SFS
Anti-Salmonella Pullorum Serum （Std. Form S） SPDS-S2
Anti-Salmonella Pullorum Serum （Variant Form V） SPDS-V
Anti-tick borne encephalitis serum TILI
Anti-tick borne encephalitis serum TISA
Anti-C complete blood typing serum,human W1004
Anti-E complete blood typing serum, human W1005
Anti-c Incomplete blood typing serum, human W1007
Anti-Varicella zoster immunoglobulin W1044
Anti smooth muscle（anti actin） autoantibody. W1062
Anti nuclear ribonucleoprotein（nRNP） autoantibody W1063
Anti-Nuclear factor serum,homogenous（66/233） W1064
Rheumatoid Arthritis serum. W1066

Vaccines
MAPREC assay of poliovirus type 1 （Sabin）.100% 480-A, 525-C DNA（1st International Reference Preparation） 00/410
MAPREC assay of poliovirus type 1 （Sabin） Low Mutant Virus Reference（1st International Reference Preparation） 00/416
MAPREC assay of poliovirus type 1 （Sabin） （1st International Standard） 00/418
MAPREC assay of poliovirus type 1 （Sabin） High Mutant Virus Reference（1st International Reference Preparation） 00/422
Influenza anti A/Singapore/1/57 Serum （sheep） H2 00/440
Influenza anti B/Yamanashi/166/98 Serum （sheep） 00/442
Diphtheria Antitoxin Human Serum 00/496
Botulinum Antitoxin Human 00/500
Influenza Virus infectious B/Sichuan/379/99 00/530
Influenza Virus infectious B/Johannesburg/5/99 00/532
Influenza anti A/Chick/Scotland/59 （H5N1） Serum （sheep） 00/542
Influenza Virus infectious B/Victoria/504/00 00/544
Influenza Antigen B/Johannesburg/5/99 00/546
Influenza Antigen A/duck/Singapore/97 （H5N3） 00/552
Influenza anti B/Johannesburg/5/99/ Serum （sheep） 00/556
Influenza Virus infectious B/Guangdong/120/00 00/614
Anti-Meningococcal immunotype L3,7,9 mAb 01/412
Meningococcal group Y polysaccharide 01/426
Meningococcal group W135 polysaccharide 01/428
Influenza anti B/Guangdong/120/2000 Serum （sheep） 01/450
Influenza anti A/Panama/2007/99 Serum （sheep） 01/452
Botulinum Antitoxin Equine Type F 01/506
Botulinum Antitoxin Equine Type C 01/508
Botulinum Antitoxin Equine Type G 01/512
Anti-Meningococcal Serosubtype P1.7 mAb 01/514
Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] 01/528
Oral Poliovaccine Sabin Reference Preparation Type 2 01/530
Oral Poliovaccine Sabin Reference Preparation Type 3 01/532
Anti-Meningococcal Serosubtype P1.16 mAb 01/538
Influenza Antigen B/Guangdong/120/2000 01/546
Influenza Virus infectious B/Hawaii/10/01 01/612
Influenza Antigen A/New Caledonia/20/99 01/614
Influenza anti A/Panama/2007/99 Serum （sheep） 02/102
Anti-Meningococcal Serosubtype P1.15 mAb 02/144
Anti-Meningococcal Serosubtype P1.4 mAb 02/148
Diphtheria Toxoid for use in Flocculation Test. 02/176
Anti-Meningococcal Serosubtype P1.2 mAb 02/178
Anti-Meningococcal Serotype P2.2a mAb 02/180
Anti-Japanese Encephalitis Virus Plasma, Human 02/182
Anti-Japanese Encephalitis （Anti-JE） Virus Control Plasma, Human 02/184
Anti-Dengue Virus Types 1+2+3+4, Human 02/186
Haemophilus influenzae b PRP 02/208
Tetanus Toxoid Not Adsorbed 02/232
Influenza Virus infectious B/Brisbane/32/2002 02/262
Influenza anti A/chick/Italy/13474/99 （H7N1） Serum （sheep） 02/294
Polio Virus Sabin Types 1, 2 and 3 02/306
Anti-Meningococcal Serotype P3.4 mAb 02/308
Anti-Meningococcal Serotype P3.15 mAb 02/310
Botulinum Antitoxin Equine Type E 02/318
Anti-Meningococcal Serosubtype P1.3 mAb 02/320
Influenza Antigen A/New Caledonia/20/99 02/336
Influenza anti A/Panama/2007/99 Serum （sheep） 02/338
Influenza anti B/Shangdong/9/97 Serum （sheep） 03/110
Anti-Meningococcal Serosutype P1.1 mAb 03/114
Anti-Meningococcal Serosubtype P1.14 mAb 03/142
Anti-Meningococcal Serotype P3.21 mAb 03/182
Influenza Virus infectious A/Kumamoto/102/02 03/198
Anti-Meningiococcal Serosubtype P1.6 mAb 03/210
Influenza anti A/Wyoming/03/03 Serum 03/212
Influenza Antigen A/Wyoming/03/03 03/220
Anti-Meningococcal Serosubtype P1.10 mAb 03/224
Anti-Meningococcal Serosubtype P1.5 mAb 03/226
Anti-Meningococcal Serosubtype P1.13 mAb 03/236
Influenza anti A/Puerto Rico/8/34 （H1N1） HA Serum 03/242
Influenza anti A/chick/Germany/N/49 （H10N7） HA Serum （sheep） 03/244
Influenza Antigen A/New Caledonia/20/99 （IVR-116） 03/258
Anti-Meningococcal Serosubtype P1.12 mAb 04/122
Tetanus Toxoid For Flocculation Test 04/150
Influenza Virus infectious NYMC X-147 04/160
Influenza Virus infectious A/Wellington/1/2004 04/170
Influenza Virus infectious IVR-139 04/172
Anti-Meningococcal Serotype P3.1 mAb 04/198
Influenza Antigen B/ Jiangsu/10/2003 04/202
Influenza anti A/Vietnam/1194/04 （NIBRG-14） HA Serum （sheep SH440&SH442） 04/214
Influenza anti B/ Neuraminidase Serum 04/228
Influenza anti N1 Neuraminidase Serum 04/230
Influenza anti B/Jiangsu/10/2003 HA Serum （sheep） 04/242
Anti-Meningococcal Serogroup W-135 mAb 04/246
Anti-Meningococcal Serosubtype P1.19 mAb 04/248
Influenza Virus infectious A/New York/55/2004 04/254
Influenza anti N2 Neuraminidase Serum（prepared from A/Wyoming/3/2003） 04/258
Influenza anti A/New Caledonia/20/99 HA Serum （sheep） 04/260
Influenza anti A/New York/55/2004 HA Serum （sheep） 04/262
Influenza Antigen A/New York/55/2004 （H3N2） （NYMC X-157） 04/264
Influenza Virus infectious NYMC BX-7 05/102
Influenza Virus infectious A/California/7/2004 05/110
Anti-human papillomavirus type 16 serum （1st International Standard） 05/134
Influenza Virus infectious B/Shanghai/361/2002 05/138
Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 05/190
Anti Meningococcal Serotype P2.2b Monoclonal Antibody 05/192
Influenza Virus infectious A/Hiroshima/52/2005 05/232
Influenza Antigen A/Wisconsin/67/2005 – Like 05/234
Influenza anti A/Wisconsin/67/2005 Serum （sheep） 05/236
Influenza Virus infectious NYMC X-161 05/244
Anti Dengue, WHO Reference Panel 05/248
Influenza anti B Neuraminidase Serum （Sheep SH463） 05/252
Influenza Antigen A/Wisconsin/67/2005 （H3N2） （NYMCX-161） 06/106
Influenza Virus infectious IVR-116 06/108
Influenza Virus Infectious A/PR/8/34 06/114
Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 （1st International Standard） 06/124
Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 （1st International Standard） 06/128
Pertussis Antiserum （human）1st IS – WHO international Standard. 06/140
Pertussis Antiserum （Human） 1st WHO Reference Reagent 06/142
Influenza Virus infectious 1 VR-142 06/164
Influenza Antigen A/New Caledonia/20/99 06/170
Influenza Virus infectious A/Wisconsin/67/2005 06/184
Influenza anti A/turkey/Turkey/1/05 （NIBRG-23） HA serum（sheepSH465 & SH466） 06/192
Medium Titre Meningococcal OMV Ref. serum 06/210
Influenza Virus infectious A/Solomon Islands/3/2006 07/132 06/236
Influenza Virus infectious NYMC-X161 B 06/242
Influenza Antigen A/Solomon Islands/3/2006 （IVR-145）（H1N1） 07/102
Influenza anti A/Solomon Islands/3/2006 （H1N1） （IVR-145） HA Serum （sheep 467,468,469,470） 07/104
Influenza Antigen A/turkey/Turkey/1/2005 （H5N1） NIBRG-23 07/112
Influenza Virus infectious B/Malaysia/2506/2004 07/132
Influenza Virus infectious IVR-145, 07/144
Influenza anti A/HongKong/1073/99 like HA Serum （sheep） 07/146
Influenza anti A/Vietnam/1194/04 （H5N1） HA Serum 07/148
Human Plasma Anti-Influenza H5N1 07/150
Rabies vaccine 07/162
Influenza anti B/Malaysia/2506/2004-HA Serum （sheep） 07/184
Diphtheria Toxoid （Adsorbed） （4th International Standard） 07/216
Influenza Virus Infectious A/New Caledonia/20/99 07/226
Influenza Virus Infectious IVR-147 07/246
Influenza Virus infectious NIBRG-14 07/252
Influenza Virus Infectious B/Brisbane/3/2007 07/268
BCG Vaccine of Danish 1331 sub-strain （1st WHO Reference Reagent） 07/270
BCG Vaccine of Tokyo 172 sub-strain（1st WHO Reference Reagent） 07/272
BCG Vaccine of Russian BCG-I sub-strain（1st WHO Reference Reagent） 07/274
Influenza anti A/mallard/Netherlands/12/2000 （H7） HA serum （NIBRG-60） （sheep SH474 AND SH475） 07/278
Influenza Antigen A/Anhui/1/05 （H5N1） IBCDC-RG-6 07/290
Meningococcal Group C Polysaccharide 07/318
Influenza Antigen A/mallard/Netherlands/12/00 （H7N3） NIBRG-60 07/336
Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （Sheep SH477） 07/338
Influenza Virus infectious NYMC X-171B 07/348
Influenza Virus infectious A/Uruguay/716/2007 07/354
Influenza Anti-B/Florida/4/2006 HA serum （sheep 478, 479） 07/356
Influenza Virus infectious NIB-50 07/358
Influenza Virus infectious IVR-149 07/362
Influenza Antigen A/Brisbane/59/2007 （IVR-148） （H1N1） 08/100
Influenza Virus Infectious NIBRG-91 08/108
Influenza Virus Infectious NIBRG-88 08/110
Influenza anti A/turkey/Turkey/1/05（N1） NA Serum （NIBRG-74） （Sheep SH485） 08/126
Influenza Virus Infectious B/Florida/4/2006 08/138
Influenza Antigen B/Florida/4/2006 08/140
Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （sheep SH477） 08/142
Influenza Virus Infectious NIBRG-12 08/154
Influenza Virus Infectious NIBRG-23 30060 VE3 08/156
Influenza Antigen B/Malaysia/2506/2004 08/184
Influenza anti A/chick/Hong Kong/G9/1997/（H9） HA serum （NIBRG-94）（H9N1） 08/202
Influenza Antigen Hong Kong/1073/99 （H9N2） 08/208
Influenza anti A/Cambodia/R0405050/2007 （H5） HA serum （NIBRG-86） 08/210
Influenza Antigen A/Cambodia/R0405050/2007 （H5N1） NIBRG-88 08/216
Tetanus Toxoid Adsorbed （4th International Standard） 08/218
Influenza Antigen A/chick/Hong Kong/G9/1997 （H9N2） NIBRG-91 08/228
Influenza anti A/Brisbane/10/2007- like HA serum 08/246
Influenza Antigen A/mallard/England/727/2006 （H2N3） NIBRG-107 08/268
Influenza Antigen A/Brisbane/10/2007-like （Prepared from A/Uruguay/716/2007 （NYMC X-175C）） 08/278
Influenza Virus Infectious B/Brisbane/33/2008 08/280
Influenza Virus Infectious IVR-148 08/300
Influenza virus infectious NYMC X-175C 08/304
Influenza Antigen B/Brisbane/60/2008-like 08/352
Influenza anti A/Japan/305/57 （H2） HA serum （A/Singapore/1/57-Like） （Sheep SH398） 08/356
Influenza Virus Infectious BX-31 08/360
Influenza Antigen A/New York/107/2003 （H7N2） NIBRG-109 08/362
Influenza Virus Infectious NIB-58 08/364
Influenza anti A/mallard/England/727/2006 （N3） NA serum （NIBRG-107） （Sheep SH503） 09/100
Influenza Virus Infectious NIBRG-122 09/130
Influenza Antigen A/California/7/2009 （H1N1）v （NYMC-179A） （Egg derived） 09/146
Clostridium Sordellii anti-serum （1st International standard） 09/154
Influenza Virus Infectious B/Brisbane/60/2008 09/168
Anti-Meningococcal factor H binding protein variant 1 （JAR4） monoclonal antibody 09/170
Influenza Antigen A/California/7/09 （H1N1）v （NYMCX-179A） （Cell Derived） 09/174
Influenza Antigen A/Vietnam/1194/2004 （H5N1） NIBRG-14 09/184
Influenza Antibody （human） to A/California/7/2009 “like” （H1N1v） （1st International Standard） 09/194
Influenza Antigen A/California/7/2009 （H1N1v） （NIBRG-121xp） （Egg Derived） 09/196
Diphtheria Antitoxin Equine DI 09 10 iu/ml 09/204
Influenza Virus Infectious A/Perth/16/2009 09/208
Influenza Virus Infectious NYMC X-179A 09/216
Influenza Virus Infectious IVR-153 09/236
Influenza Virus Infectious NYMC X-183 09/248
Influenza Virus Infectious NIBRG-121xp 09/268
Influenza Virus Infectious NYMC X-185 09/274
Influenza Virus Infectious A/Brisbane/59/2007 09/276
Influenza Virus Infectious NIB-64 09/280
Influenza Virus Infectious NYMC X-187 09/290
Influenza Antigen A/California/7/09 （H1N1）v （NYMC-181） （Egg Derived） 09/294
Influenza Virus Infectious IVR-155 09/304
Influenza Virus Infectious NIBRG-147 09/306
Influenza Antigen A/Wisconsin/15/09 （H3N2） （NYMCX-183） 09/310
Influenza Virus Infectious NYMC X-181 09/314
Influenza Anti B Neuraminidase Serum （B/Florida/4/2006） 09/316
Influenza Virus Infectious NYMC BX-35 09/318
Influenza Antigen A/Victoria/210/09 （H3N2） （NYMCX-187） 10/102
Influenza Antigen B/Brisbane/60/2008 Reassortant （NYMC BX-35） 10/106
Influenza Antiserum A/Brisbane/59/2007 （H1N1）（IVR-148） HA （sheep 516 and 517） 10/120
Influenza Virus Infectious A/California/7/2009 10/122
Diphtheria Polyclonal Antibody 10/128
Diphtheria Monoclonal Antibody 10/130
Tetanus Polyclonal Antibody 10/132
Tetanus Monoclonal Antibody 10/134
Influenza Anti-B/Brisbane/60/2008 HA serum 10/146
Influenza Anti-A/Perth/16/2009 HA Serum 10/182
Influenza Anti A/Hong Kong 1073/99 （N2）NA Serum （Sheep SH395 SH396） 10/214
Influenza Virus Infectious NIB-74 10/216
Influenza Anti A/California/7/2009 （N1） NA Serum （Sheep SH 521） 10/218
Influenza Virus Infectious IVR-158 10/226
Influenza Anti-A/California/7/2009 （H1N1） HA Serum 10/230
Influenza virus infectious B/Brisbane/60/2008 30990 E6 10/244
Clostridium Perfringens Beta Antitoxin 2CPBETAAT
Clostridium Perfringens Epsilon Antitoxin 2CPEPSILONAT
Gas Gangrene （Cl. Perfringens（Cl. Welchii） Type A）, Equine 59/015
Botulinum Antitoxin Equine Type A 59/021
Botulinum Antitoxin Equine Type B 60/001
Tetanus Antitoxin, Equine, for Bioassay 60/013
Botulinum Antitoxin Equine Type D 61/001
Gas Gangrene Antitoxin （Cl. Histolyticum）, Equine 63/005
Diphtheria Antitoxin, Equine, for Flocculation Test 63/007
Gas Gangrene Antitoxin （Cl. Septicum）, Equine 64/014
Gas Gangrene Antitoxin （Cl. Oedematiens）, Equine 64/024
Tetanus Antitoxin, Equine, for Flocculation Test 66/021
Diphtheria Antitoxin, Equine 66/153
Anti-Rubella Serum, Human 67/182
Diphtheria Toxoid, Plain 69/017
Cholera Vaccine （Inaba） 73/554
Opacity 5IRP 76/522
Influenza anti A/Victoria/3/75 Serum（goat） 76/547
Tetanus Antitoxin, Human, Immunoglobulin 76/589
Influenza Antigen A/New Jersey/8/76 77/530
Influenza anti A/New Jersey/8/76 （H1N1） Serum（sheep） 77/531
Influenza anti B/Hong Kong/8/73 Serum（sheep） 77/568
Influenza Antigen A/Texas/1/77 78/560
Influenza anti A/Texas/1/77 Serum （sheep） 78/569
Influenza anti A/Brazil/11/78 Serum （goat） 79/516
Influenza Antigen A/USSR/92/77 79/552
Influenza Antigen A/USSR/92/77 79/558
Influenza Antigen A/Brazil/11/78 79/560
Influenza Antigen B/Hong Kong/8/73 79/568
Influenza Antigen A/Bangkok/1/79 80/517
Influenza Antigen B/Singapore/222/79 80/519
Influenza anti B/Singapore/222/79 Serum 80/523
Influenza anti A/Bangkok/1/79 Serum （sheep） 80/525
Anti Poliovirus serum types 1,2 and 3 82/585
Influenza Antigen A/Philippines/2/82 83/537
Influenza anti A/Philippine/2/82 Serum （sheep） 83/545
Influenza Antigen A/Brazil/11/78 83/550
Influenza Antigen A/Chile/1/83 84/538
Influenza Antigen B/Norway/1/84 84/542
Influenza anti B/USSR/100/83 Serum（sheep） 84/636
Influenza anti A/Chile/1/8 Serum（sheep） 84/640
Influenza anti A/equine/Prague/56 （H7N7） Serum（goat） 84/673
Influenza anti A/equine/Miami/63 （H3N8） Serum（goat） 84/677
Influenza anti A/Equine/Kentucky/1/81 HA Serum （sheep） 85/516
Influenza Antigen A/Equine/Kentucky/1/81 85/520
Influenza Antigen A/Equine/Prague/56 （H7N7） 85/553
Influenza Antigen A/Mississippi/1/85 86/576
Influenza anti A/Mississippi/1/85 Serum（sheep） 86/590
Influenza anti B/Ann Arbor/1/86/HA Serum （sheep） 86/592
Influenza Antigen B/Ann Arbor/1/86 86/630
Influenza Antigen A/Equine/Miami/63 87/510
Influenza anti A/Leningrad/360/86 Serum （sheep） 87/578
Influenza Antigen A/Leningrad/360/86 87/584
Influenza Antigen A/Sichuan/2/87 87/714
Influenza Antigen B/Victoria/2/87 87/774
Bordela pertussis （Whole cell vaccine） 3BRP 88/522
Influenza Antigen B/Beijing/7/87 88/554
Influenza Antigen A/England/427/88 88/654
Influenza anti A/Sichuan/2/87 Serum（sheep） 88/672
Influenza anti B/Beijing/1/87 Serum（sheep） 88/678
Influenza anti A/England/427/88 Serum（sheep） 88/846
Anti-Bordela pertussis serum （Human） 89/530
Influenza Antigen A/OMS/5389/88 89/568
Bordela pertussis （W28） LPS 2ug 89/594
Bordela pertussis anti-agglutinogen 1（rabbit） 89/596
Bordela pertussis anti-agglutinogen 2 （rabbit） 89/598
Bordela pertussis anti-agglutinogen 3 （rabbit） 89/600
Bordela pertussis （W28） LPS25ug 89/670
Influenza Antigen A/Shanghai/16/89 90/500
Influenza Antigen A/Guizhou/54/89 90/502
Influenza anti A/Guangdong/39/89 Serum（sheep） 90/504
Bordela Pertussis toxin （PT） 90/518
Bordela pertussis, filamentous haemagglutinin （FHA） 90/520
Mumps Vaccine （Live） 90/534
Bordela pertussis 69kD 90/654
Influenza Virus infectious NIB-26 （H3N2） 90/784
Poliomyelitis Vaccine （Inactivated） 91/574
Influenza anti A/Taiwan/1/86 Serum （sheep） 91/612
Influenza Virus infectious A/Texas/36/91 （H1N1） 91/660
Influenza Virus infectious NIB-27 （H1N1） 91/670
Rubella Vaccine （Live） 91/688
Influenza Antigen A/Texas/36/91 92/530
Influenza anti B/Yamagata/16/88 Serum（sheep） 92/582
Influenza Antigen B/Yamagata/16/88 92/628
Influenza anti A/Beijing/352/89 （H3N2） Serum （sheep） 92/632
Measles Vaccine （Live） 92/648
Influenza Virus infectious A/Beijing/32/92 （H3N2） 92/734
Influenza Virus infectious A/Shanghai/24/90 92/738
Influenza Antigen A/Beijing/32/92 93/500
Influenza Antigen A/Shanghai/24/90 93/516
Influenza anti A/Beijing/32/92 （H3N2） Serum （sheep） 93/518
Influenza anti A/Shanghai/24/90 （H3N2） Serum （sheep） 93/522
Influenza Virus infectious A/Beijing/359/89 （H3N2） 93/568
Influenza Virus infectious A/Guizhou/54/89 （H3N2） 93/572
Influenza Virus infectious A/Shangdong/9/93 （H3N2） 93/686
Influenza Virus infectious B/Panama/45/90 93/692
Influenza Virus infectious A/Harbin/15/92 （H3N2） 93/816
Influenza Antigen B/Panama/45/90 94/500
Influenza anti A/Shanghai/9/93 Serum（sheep） 94/504
Influenza Antigen A/Shangdong/9/93 94/516
Influenza anti B/Panama/45/90 Serum（sheep） 94/520
Pertussis Vaccine Whole Cell 94/532
Influenza Virus infectious A/Johannesburg/33/94 （H3N2） 94/758
Influenza Virus infectious B/Beijing/184/93 94/760
Influenza Virus infectious RESVIR-8 （H3N2） 94/762
Influenza Virus infectious NIB-34 （H3N2） 94/766
MAPREC analysis of Poliovirus type 3 （Sabin）. Synthetic DNA 100% 472-C 94/790
Hepatitis A Vaccine, inactivated 95/500
Influenza Antigen A/Texas/36/91 95/510
Influenza Antigen A/Johannesburg/33/94 95/516
Influenza anti A/Johannesburg/33/94 Serum（sheep） 95/524
Influenza anti A/Taiwan/1/86 Serum （H1N1） 95/536
MAPREC analysis of Poliovirus type 3 （Sabin） Synthetic DNA 0.9% 472-C 95/542
Anti-Meningococcal Serogroup A mAb 95/674
Anti-Meningococcal Serogroup C mAb 95/678
Anti-Meningococcal Serogroup B mAb 95/750
Influenza Virus infectious A/Wuhan/359/95 （H3N2） 95/758
Anti-Hib Human Reference Serum 96/536
MAPREC analysis of Poliovirus type 3 （Sabin） Low virus reference 0.7%472-C 96/572
MAPREC analysis of Poliovirus type 3 （Sabin） High virus reference 1.1%472-C 96/578
Influenza Virus infectious A/Bayern/7/95 96/830
Influenza Virus infectious RESVIR-9 （H3N2） 96/836
Influenza Virus infectious A/Shenzhen/227/95 （H1N1） 96/848
Influenza Virus infectious NIB-39 （H1N1） 96/850
Influenza Antigen A/Johannesburg/82/96 97/518
Bordela pertussis anti 69kD serum （sheep） 97/558
Bordela pertussis anti FHA serum （sheep） 97/564
Bordela pertussis PT anti serum （sheep） 97/572
Bordela pertussis anti Fim3 serum （sheep） 97/574
Influenza Antigen A/Equine/Newmarket/2/93 97/584
Influenza Antigen A/Equine/Newmarket/1/93 97/596
Influenza anti A/equine/Newmarket/1/93 Serum（sheep） 97/610
Influenza anti A/Nanchang/933/95 （H3N2） 97/612
Influenza anti A/Equine/Newmarket/2/93 （H3N8） HA Serum （SH-376） 97/614
Bordela pertussis anti serum （mouse） 1RR 97/642
Anti-Measles serum 97/648
AntiStreptolysin O 97/662
Influenza Virus infectious IVR-108 （H3N2） 97/692
Influenza Virus infectious A/duck/Sing-Q/119/97 （H5N3） 97/722
Influenza Virus infectious B/Harbin/7/94 97/726
Influenza Antigen B/Harbin/7/94 97/748
MAPREC analysis of Poliovirus type 2 （Sabin）, low virus reference 0.65%481-G 97/756
MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA 0.67%481-G 97/758
Influenza Antigen A/Beijing/262/95 97/760
MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA, 100%481-G 98/524
Influenza Virus infectious RESVIR-13 （H3N2） 98/544
Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 98/572
MAPREC analysis of Poliovirus type 2 （Sabin）, high virus reference 1.21% 481-G 98/596
Influenza Virus infectious NIB-40 （H5N3） 98/600
Influenza anti B/Harbin/7/94/HA Serum （sheep） 98/604
Influenza Virus infectious ARIV-1 （H5N3） 98/610
Influenza anti A/Hong Kong/489/97 （H5N1） Serum （sheep） 98/666
Control Guinea Pig Serum 98/686
Meningococcal group A polysaccharide 98/722
Influenza Virus infectious Resvir-14 （H3N2） 98/762
Influenza anti A/Beijing/262/95 Serum （sheep） 98/772
Influenza Antigen B/Shangdong/7/97 98/774
Influenza Virus infectious A/Sichuan/346/98 （H3N2） 98/778
Anti-PT S1 subunit Monoclonal Antibody （1B7） 99/506
Anti-PT S1 subunit Monoclonal Antibody （1D7） 99/508
Anti-PT S1 subunit Monoclonal Antibody （3F11） 99/510
Anti-PT S1 subunit Monoclonal Antibody （10D6） 99/512
Anti-PT S1 subunit Monoclonal Antibody （8G4） 99/514
Anti-PT S1 subunit Monoclonal Antibody （E1E） 99/516
Anti-PT S1 subunit Monoclonal Antibody （E2E） 99/518
Anti-PT S1subunit Monoclonal Antibody （3F10） 99/520
Anti-PT S1 subunit Monoclonal Antibody （11D9） 99/522
Anti-PT S1 subunit Monoclonal Antibody （4D10） 99/524
Anti-PT S23 subunit Monoclonal Antibody （11E6） 99/526
Anti-PT S23 subunit Monoclonal Antibody （10C9） 99/528
Anti-PT S23 subunit Monoclonal Antibody （10B5） 99/530
Anti-PT S23 subunit Monoclonal Antibody （G9A） 99/532
Anti-PT S23 subunit Monoclonal Antibody （3F6） 99/534
Anti-PT S2 subunit Monoclonal Antibody （3A12） 99/536
Anti-PT S2 subunit Monoclonal Antibody （2H3） 99/538
Anti-PT S2 subunit Monoclonal Antibody （9G8） 99/540
Anti-PT S3 subunit Monoclonal Antibody （7E10） 99/542
Anti-PT S3 subunit Monoclonal Antibody （7G11） 99/544
Anti-PT S3 subunit Monoclonal Antibody （4G5） 99/546
Anti-PT S3 subunit Monoclonal Antibody （2E12） 99/548
Anti-PT S3 subunit Monoclonal Antibody （6F8） 99/550
Anti-PT S4 subunit Monoclonal Antibody （7F2） 99/554
Anti-PT S4 subunit Monoclonal Antibody （6B3） 99/556
Anti-PT S4 subunit Monoclonal Antibody （6G8） 99/558
Anti-PT S4 subunit Monoclonal Antibody （9F3） 99/560
Anti-PT S4 subunit Monoclonal Antibody （1H2） 99/562
Anti-PT S4 subunit Monoclonal Antibody （9C6） 99/564
Anti-PT S4 subunit Monoclonal Antibody （6D6） 99/566
Anti-PT S5 subunit Monoclonal Antibody （7E3） 99/568
Anti Filamentous Haemagglutinin Monoclonal Antibody （1C6） 99/570
Anti-Filamentous haemagglutinin Monoclonal Antibody （2E9） 99/572
Anti Filamentous Haemagglutinin Monoclonal Antibody （12G10） 99/574
Influenza Antigen B/Yamanashi/166/98 99/586
Methylated Human Serum Albumin （mHSA） 99/592
Influenza Antigen A/Sydney/5/97 99/614
Yellow Fever Vaccine 99/616
Influenza Antigen A/Sydney/5/97 99/624
Anti-Meningococcal human reference serum CDC1992 99/706
Influenza Antigen A/Singapore/1/57 （H2N2） 99/714
Influenza Virus infectious RESVIR 16 （H3N2） 99/824
Influenza Antigen B/Yamanashi/166/98 99/828
Botulinum Antitoxin Equine Type B BUSB
Clostridium novyi （alpha） Toxoid COT
Clostridium Welchii （Perfringens）（Beta） Toxoid CwBT CWBETATD
Clostridium Welchii （Perfringens）（ Epsilon） Toxoid CwDT CWEPSILONTD
Bordela pertussis anti FHA serum （mouse） JNIH-11
Bordela pertussis PT（ LPF） anti serum, （mouse） JNIH-12
Acellular Pertussis Vaccine – 1st IS JNIH-3
Bordela pertussis filamentous haemagglutinin （FHA） JNIH-4
Bordela pertussis toxin （PT） 1st IS JNIH-5
Newcastle Disease Vaccine （Inactivated） NVIA
Gas Gangrene Antitoxin （Cl. novyi）, Equine OE
Gas Gangrene Antitoxin （Cl. Perfringens alpha antitoxin） Equine PE
Purified Protein Derivative （PPD） of M Avium Tuberculin PPDA
Purified Protein Derivative （PPD） of Bovine Tuberculin PPDBOV
Purified Protein Derivative （PPD） of M. Tuberculosis Tuberculin PPDT
Anti-rubella Immunoglobulin, Human RUBI-1-94
Smallpox Vaccine SMV
Anti-Staphylococcal P-V Leucocidin serum, Equine SPLS
Staphylococcus Alpha Antitoxin, Equine STA
Diphtheria （Schick） Test Toxin STT
Tetanus Immunoglobulin, Human TE-3
Typhoid Vaccine （acetone-inactivated） TYVK
Typhoid Vaccine （heat-phenol-inactivated） TYVL
Gas Gangrene Antitoxin （Cl. Septicum）, Equine VI
Anti-Yellow Fever Serum, monkey YF